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Abstract 
When cells are infected with virus, a chain of biochemical processes are initiated to protect 
the host cell and organism. Some of these processes are effectuated immediately (innate 
immunity) whilst other processes might need several days before becoming effective 
(adaptive immunity). An essential part of the innate immune system is the receptors which 
recognize extracellular or endocytosed/phagocytosed foreign organisms (TLR). In addition 
there are cytoplasmic receptors (the RLHs RIG-I and MDA-5 or the NLRs) that initiate 
signaling cascades upon interaction with foreign macromolecules. When these receptors bind 
foreign molecules, chain-reactions lead to the synthesis and secretion of interferons, certain 
interleukins, and the activation of different caspases mediating regulated cell-death 
(apoptosis). The NLRs recognize bacterial components like peptidoglycan containing 
diaminopimelic-acid or muramyl dipeptide, while the RLHs recognize viral components [1]. 
When RIG-I bind to viral RNA, down-stream signaling leads to the activation of a 
mitochondrial antiviral signaling protein (MAVS) that result in increased production of 
interferon. Activation of virus responsive genes is not always sufficient for protection of 
salmon against acute infections with the highly pathogenic viruses.  
The diseases causing the highest ecological and economic impacts in farmed fish in Europe 
are caused by RNA-viruses. In this thesis two pathogenic viruses that are the causative agents 
of two important fish diseases in aquaculture are studied; Infectious Salmon Anemia Virus 
(ISAV) and Infectious Pancreatic Necrotic Virus (IPNV). Cell lines from Atlantic salmon 
were infected with these viruses to study the intracellular biochemical changes that are 
initiated upon infection. In this thesis the importance of the pattern recognition receptor RIG-I 
and the signaling protein MAVS were studied by transfecting cells with plasmids containing 
genes coding for these proteins. The effect of overexpressing these proteins on virus 
replication and CPE were analyzed. In addition to this, the subcellular localization of these 
proteins was studied by transfecting cells with plasmids coding for variants of RIG-I and 
MAVS protein fused to Green Fluorescent Protein (GFP). Fluorescence microscopy was 
utilized to observe and study the effect of virus infection on intracellular localization. Our 
findings do not conclusively demonstrate that overexpression of RIG-I or MAVS protect the 
cells from ISAV or IPNV infection.   
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Glossary 
The following abbreviations are used in the text. 
ASK Atlantic salmon kidney cell line 
BSA Bovine serum albumine 
CARDs Caspase activation and recruitment domain 
CARDIF CARD adaptor inducing IFN-β 
CAMs Cell adhesion molecules 
CHSE Chinook salmon embryo cells 
CMV Cytomegalo virus 
CPE Cytopathic effect 
CPM Cumulative percent mortality 
Cq Quantification cycles 
DAPI 4,6-diamino-2-phenylindole, used for nuclear staining 
dNTPs deoxynucleotide triphosphates 
DPI Days post infection 
DPT Days post transfection 
dsRNA Double-stranded RNA 
EDTA Ethylenediaminetetraacetic acid 
EF1α Elongation factor 1 alfa 
GFP Green fluorescent protein 
GRP78 Glucose regulated protein 78 
HE Hemagglutinin-esterase 
IFN Interferon 
IKK Inhibitor of NF-κB kinase 
Il1β Interleukin 1β 
IPS-1 Interferon-β promotor stimulator 1 
IPNV Infectious pancreatic necrotic virus 
IRF-3 Interferon regulatory factor 3 
ISAV Infectious salmon anemia virus 
ISG15 Interferon stimulated gene 15 
LB-medium Luria Bertani medium 
MAVS Mithochondrial antiviral signaling protein 
MDA-5 Melanoma differentiation-associated gene 5 
MCS Multiple cloning sites 
MOI Multiplicity of infection 
NF-κB Nuclear factor κB 
NLRs NOD-like receptors 
NTC No-template controls 
ORF Open reading frames 
PAMPs Pathogen associated molecular patterns 
PBS Phosphate buffered saline 
Poly I:C Polyriboinosinicpolyribocytidylic acid 
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PRR Pathogen recognition receptor 
qPCR quantitative real time polymerase chain reaction 
RD Regulatory/repressor domain 
RIG-I Retinoic acid inducible gene I 
RLHs RIG-like helicases 
RLR RIG-I like receptors 
rpm Rotations per minute 
RPS Relative percent survival 
RT-PCR Reverse transcription polymerase chain reaction 
SF2 Superfamily 2 
TBK-1 TANK-binding kinase 1 
TCID50 Tissue culture infectious dose 50% 
TNFα Tumor necrosis factor α 
VISA Virus-induced signaling adaptor 
VRG Virus responsive genes 
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1: Introduction 
1.1: Atlantic salmon 
Atlantic salmon (Salmo salar L.) are anadromous fish, i.e. they hatch in fresh water, spend 
adult life stages in ocean water and then return to fresh water to spawn. Pre-adaption to a life 
in the sea happens while the salmon is still in fresh water and is termed smoltification. This is 
a complex transitional life stage which includes both morphological and physiological 
changes regulated by several endocrine systems [2]. Although Atlantic salmon is prone to 
infections during all life stages, it has been observed that for example Infectious Pancreatic 
necrosis virus gives higher mortalities and has the highest incidents in fry and post-smolts, as 
the salmon’s immune system is not yet fully developed [3]. Below, a figure displaying the 
different life stages for salmon is shown. 
 
Figure 1: Salmon life stages [4]  
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Adult salmon lay their eggs in fresh water in special nests in the gravel, during the autumn. 
The eggs hatch in the spring into alevins. Alevins live off their yolk sacs while still under the 
gravel. When the yolk sacs have been used up, they have to start feed, and are then called fry. 
The salmon are known as parr when they are over a year old. The parr change into smolts in 
their second, third or fourth year and is the process where the salmon is preparing to head out 
to sea. The adult salmon travels great distances at sea where it feed for one to four years 
before returning to fresh water to spawn. Adult salmon returning to spawn is known as grilse. 
After the grilse has spawned they are known as kelts [4].     
1.2: Orthomyxoviridae 
Infectious salmon anemia is an orthomyxovirus infection caused by the aetiological agent 
Infectious Salmon Anemia Virus, the only virus in the Isavirus genus.  
Orthomyxoviridae (orthos, Greek for straight, and myxa, Greek for mucus) is a family with 
negative-sense RNA genomes, i.e. a class V in the Baltimore classification. By the molecular 
biologist’s convention, mRNA is defined as a positive (+) strand because it contains 
immediately translatable information. In the Baltimore classification, a strand of DNA that is 
of equivalent sequence is also designated a (+) strand. The RNA and DNA complements of 
(+) strands are designated negative (-) strands [5]. By definition negative-sense RNA 
genomes cannot be translated directly into protein but first must be copied to make positive-
sense mRNA by a viral RNA-dependent RNA polymerase [5]. There are no enzymes in the 
cell that can produce mRNAs from the RNA genomes of negative-sense RNA viruses. 
Therefore the virus particles contain virus-encoded, RNA-dependent RNA polymerases to do 
the task. The negative-sense strand also serves as a template for the synthesis of full-length 
positive-sense strands, and this newly synthesized antigenome (+) strand is in turn copied to 
produce negative-sense strand genomes [5]. All viruses with negative sense RNA genomes 
encode a NP which binds ssRNA. In orthomyxoviruses, the NP is the major structural protein 
that interacts with the RNA segments, and its primary function is to encapsidate the virus 
genome to facilitate RNA transcription, replication and packaging [6]. 
Other members of this family include the Influenza viruses A, B and C, the Thogotovirus and 
Dhori viruses, but the Isavirus is the only virus in the orthomyxoviridae family causing 
disease in fish that has been described so far. The Influenza viruses of the Orthomyxoviridae 
family depend on higher vertebrates as hosts. In contrast to types B and C, type A is a 
respiratory pathogen for a wide mammalian host range, including humans, pigs, horses, and 
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sea mammals, and an enteric virus of many avian species worldwide. In contrast, Thogoto and 
Dhori viruses replicate in both vertebrate and tick cells and are transmitted by tick bite [7]. 
 1.2.1: Infectious Salmon Anemia Virus (ISAV) 
This virus was reported for the first time from an outbreak in Norway in 1984 [8]. ISAV 
cause 15-100% mortalities in Atlantic salmon, and has emerged as a great concern to 
aquaculture industry in Europe and Chile imposing great economic losses. Chile lost its 
second place after Norway as the world’s top producer of Atlantic salmon after one outbreak, 
and the production in 2010 was just 1/10 of Chile’s production in 2006 [9]. Since the first 
outbreak in Norway, ISAV has also been reported from Atlantic salmon in Canada, USA, 
Scotland and the Faroe Islands, but also in Coho salmon in Chile [8].  In this thesis the 
ISAV4-strain was used. This strain was kindly provided by Birgit Dannevig at the National 
Veterinary Institute, Oslo. In a laboratory infection experiment comparing 11 different strains 
of ISAV, this strain was characterized with relatively high mortality [10]. Little is known of 
the replication cycle of ISAV, but what we do know is that the optimal replication 
temperature for ISAV is 15°C and that it does not occur in temperatures above 25°C and that 
replication and transcription occur in the cell nucleus [6, 7, 9]. This virus shares several 
genetic, biochemical and morphological properties with Influenza viruses [7].  
1.2.2: Virion structure and proteins of ISAV 
ISAV is an enveloped, polymorphic single-stranded RNA-virus consisting of 8 RNA 
segments with negative sense polarity [8, 11]. The viral genome encodes at least ten different 
proteins, (nine of which are structural) two of them with suggested interferon antagonistic 
effect. Segment 7 and 8 contains two open reading frames (ORF). The ORF1 of segment 7 
encodes a nonstructural protein with interferon antagonistic properties, and the ORF2 of 
segment 8 encodes an RNA-binding structural protein which also has type I interferon 
antagonistic properties [11]. One of the most important features with this virus causing 
virulence, is in the surface protein hemagglutinin-esterase (HE) [3]. HE is one of the most 
variable of the ISAV genes, exhibiting a length polymorphism close to the 3’ end called 
highly polymorphic region (HPR), and is responsible for receptor-binding [12]. The HE 
protein-stem length and ISAV virulence has been related although this is not entirely clear 
[8].  
Virions consist mainly of a lipid membranous envelope derived from the plasma membrane of 
the host cell with two protruding surface glycoproteins (fusion (F) protein and HE) and a 
matrix protein surrounding a ribonucleoprotein complex [12]. One of these surface 
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glycoproteins consist of a combination of receptor-binding hemagglutinin with receptor-
destroying enzyme activity, and is termed the hemagglutinin-esterase (HE) and is thus 
responsible for both viral attachment and release. ISAV binds to 5-N-acetyl-4-O-acetylsialic 
acid and this sugar is also the substrate for the esterase activity in HE [13]. ISAV is closely 
related to the Influenza A and B viruses in that their RNA is divided into 8 segments, but for 
the latter viruses, the receptor-binding and receptor-destroying activity is divided between two 
different proteins; hemagglutinin (which also contain the fusion activity) and neuraminidase. 
Influenza C viruses encodes a unique multifunctional surface glycoprotein with all three 
functions (receptor-binding, receptor-destroying and fusion activity) in the same protein; 
hemagglutinin-esterase-fusion protein (HEF), and their RNA genome are divided into 7 RNA-
segments [14]. Also the assignments of the genome segments encoding the proteins in ISAV 
differ from those of influenza A and B viruses as displayed below where Isavirus and 
Influenzavirus A are compared. 
 Table 1: Comparison of genome coded assignments for Isavirus and Influenzavirus A 
Genome 
segment  Gene products
1
   
  Isavirus  Influenzavirus A 
1 PB2 (84 kDa)2  PB1 (96 kDa) 
2 PB1 (84 kDa)  PB2 (87 kDa) 
3 NP (77 kDa)  PA (85 kDa) 
4 PA (71 kDa)  HA1 (48 kDa), HA2 (29 kDa) 
5 gp50 (47 kDa)  NP (50–60 kDa) 
6 HE (42 kDa)  NA (48–63 kDa) 
7 p32 (32 kDa), NEP (18 kDa), p11 (11 kDa)  M1(25 kDa), M2 (15 kDa) 
8 M1 (24 kDa), NS1 (16 kDa)  NS1(25 kDa), NS2 (12 kDa) 
 
Table 1: 
1
Gene products: PB2, PB1 and PA, polymerase; NP, nucleoprotein; HA, 
hemagglutinin (two subunits in Influenzavirus A); gp50 a fusion protein F (Aspehaug et 
al.,2005)[15]; HE, hemagglutinin-esterase in Isavirus (Falk et al., 2004) [6]; NA, 
neuraminidase; M1, matrix protein (Falk et al., 2004); p32, a structural protein of unknown 
function in Isavirus; M2, ion channel protein; p11, protein of unknown status and function in 
Isavirus; NS1, non-structural protein 1; NS2, non-structural protein 2 (also known as nuclear 
export protein, NEP). Table taken from Kibenge et. al. 2004 [16]. 
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1.2.3: Clinical features and pathology of ISAV 
In general, infection with ISAV is related mainly to damage of the organs with viral loads 
highest in the liver, head  kidneys, spleen and intestine, before causing death of the salmon 
[11, 17]. Clinical features include severe anemia, leucopenia, exophthalmia, pale gills, ascites, 
hemorrhagic liver necrosis, renal interstitial hemorrhage, tubular necrosis and petechia in the 
viscera [7, 16, 18, 19]. Infected individuals also displays spleen inflammation [17].  
Generally, infected  Atlantic salmon with ISA appear lethargic and may keep close to the wall 
of the net pen [11]. The clinical ISA disease can also occur in wild free-ranging Atlantic 
salmon, but these fish are less susceptible than farmed Atlantic salmon, due either to genetic 
variation in the two fishes or to stress caused by management practices on salmon farms [16, 
20]. ISAV may infect and replicate in sea trout, brown trout, rainbow trout, eels, herring, and 
Arctic char, resulting in asymptomatic, probably life-long, carriers of the virus [16].  
 
Figure 2: Atlantic salmon with ISA. Dark hemorrhagic liver and intestines in infected salmon 
[3].  
 
1.2.4: Vaccines against ISAV 
 
Vaccination against ISAV is considered to be a very important strategy in controlling the 
disease, either by protecting vulnerable stocks or for a ring vaccination program. There is 
presently no effective available treatments other than destroying all fish in infected farms, 
avoiding fish movements to and from infected areas [21]. A recent study showed that the 
nucleotide analogue ribavirin had an inhibitory effect on ISAV replication [9]. Different 
vaccines against infectious salmon anemia virus have been commercialized. Pharmaq AS, 
Norway, has the Alpha Jects® vaccine which is an i.p. injection with inactivated monovalent 
ISAV, currently used in Norway and Chile, but also in Ireland and Finland under the name 
 - 18 - 
 
Micro-1 ISA, and Novartis Aqua Norway has the Pentium Forte Plus ILA vaccine which is 
also an i.p. injection vaccine. This vaccine is a multicomponent vaccine against 6 additional 
diseases. It was not until recently (in 2010) that ISA-vaccination was allowed in Norway. In 
Canada, an inactivated multivalent i.p. injection vaccine has been commercialized under the 
name FORTE VI by Aqua Health Ltd., Novartis. In Chile an oral vaccine is available from 
Centrovet Ltda. This oral vaccine is based on recombinant ISAV protein produced  in yeast,  
mixed with the feed, and can be used on salmon >10 g. However the currently available 
vaccines do not always confer complete protection, and in addition, vaccines based on 
inactivated virus must be formulated in oil-water emulsions to induce protection (and are 
frequently associated with visceral adhesions) [8]. Adjuvants acts like chemical catalysts and 
increase the response to a vaccine without any specific antigenic effect. Mineral salts, 
particulate and surfactant based formulation and particulate delivery vehicles like liposomes 
and virosomes have been used extensively as vaccine adjuvants [22]. The immune response 
against ISAV after infection or vaccination does not provide full protection against the 
infection. It has previously been discovered that antibody-mediated uptake and ISAV-
replication can occur in macrophage-like fish cell lines which may suggest that Fc (fragment 
crystallizable) receptor-mediated antibody-dependent enhancement of ISA virus infection 
might also occur in vivo, as the virus in Atlantic salmon targets endothelial cells lining blood 
vessels and macrophage-like cells [16]. Furthermore the current vaccine delivery by injection 
is not suitable for dosing large numbers of fish in a cost-effective manner. The relatively low 
cost per fish and the young age and small size coincident with the high susceptibility of fish to 
viral diseases at an early age argue against vaccination of individual fish, and highlight the 
need for means of vaccinating fry or eggs before they leave the hatching shed [16]. If methods 
of delivering DNA vaccines to first-feeding fry could be developed, these vaccines could be 
useful in protecting small fish, even before maturation of the specific immune response, early 
protection being provided by the interferon response [16].         
1.3: Birnaviridae 
Infectious pancreatic necrosis virus (IPNV) is the etiological agent of Infectious pancreatic 
necrosis. This archetypal aquatic virus belongs to the Birnaviridae-family. Characteristics of 
this family includes viruses with a bi-segmented dsRNA genome that are distinctive, small, 
nonenveloped and displays a icosahedral capsid with a diameter of 65-70 nm composed of 
260 trimers of viral protein 2 (VP2) projecting radially from the capsid [23, 24]. These viruses 
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exhibit a high degree of antigenic hereogeneity and variation in biological properties such as 
pathogenicity, host range and temperatures of replication [25].  
1.3.1: Infectious pancreatic necrosis virus (IPNV) 
Infectious pancreatic necrosis is a serious disease of salmonids and a number of other fish 
species. IPN is now recognized to be the most important disease in its impact on salmon 
production in the European Union and in Norway [26]. This could be contributed by the fact 
that IPNV affects most finfish species in their juvenile stages and causes severe economic 
losses during juvenile Atlantic salmon release from fresh water to ocean water [26]. Survivors 
after a outbreak often become persistently infected for a long period. IPNV can be isolated 
from head kidney from carrier fish, and adherent leukocytes are most likely the sites of 
persistent infection [27].  
1.3.2: Virion structure and proteins of IPNV 
IPNV are non-enveloped, and possesses a 60 nm icosahedral structure. Its genome is bi-
segmented in RNA segment A and RNA segment B, which in total encodes 5 proteins [28]. 
RNA segment A has two open reading frames, one long and one short ORF, encoding the 106 
kDa polyprotein precursor pVP2-VP4-VP3 and the nonstructural 17 kDa VP5, respectively 
[24, 29]. VP5 is nonstructural, meaning that it is only detected in infected cells, and not in the 
purified virion particle itself. During translation in the infected cell, the VP4 of the 
polyprotein, acts as a viral protease and cleaves its own N and C termini of the polyprotein 
into pVP2 (62 kDa), and VP3 (31 kDa) [29]. pVP2 is further processed by subsequent 
cleavages, yielding the mature VP2 which is the major capsid protein and type-specific 
antigen [29]. 
VP3 is an internal capsid protein, and its presence together with the mature VP2 are important 
for correct morphogenesis of icosahedral virions [24]. Since VP2 is the capsid coat protein, 
this protein displays the humoral antigenic determinants of the virus and is the main target for 
neutralizing antibodies. This protein is also involved in virus entry, being responsible for 
receptor recognition [24].        
The smaller RNA segment B has a single ORF coding for VP1, which is a minor internal 
protein of 94kDa, which is the virion-associated RNA polymerase [29]. It has been shown 
that the VP3 acts as a transcriptional activator by its interaction with VP1. VP3s C-terminal 
tail interacts with VP1 and removed the structural blockade of the polymerase active site [23].   
 - 20 - 
 
It is clear that IPNV has evolved mechanisms to overcome the IFN responses. Viral proteins 
VP4 and VP5 seem the most probable candidates responsible for interfering with the IFN-
signaling pathway in salmon [30].    
1.3.3: Clinical features and pathology of IPNV 
 
In fresh water, infected fish frequently develops a greatly distended intestine due to 
accumulation of undigested food. In sea water, after the initial losses, some of the fish that 
survives fail to grow, and become chronically emaciated and prone to sea louse infection [26]. 
In Atlantic salmon, the clinical features and pathology are similar to those found in rainbow 
trout with fry, darker in color, showing in the surface water film or at the outflows, lying on 
their side and hyperventilating, and also making characteristic shimmering movements, and 
swirling around their length axis [3, 26]. In young fry, severe necrosis of the pancreatic acinar 
cells can be observed, together with necrosis of intestinal mucosa, and sometimes some lipid 
necrosis [26]. In salmon parr, the liver of IPN-infected fish is particularly distinctive. Usually 
it is swollen, pale yellow to white in color and very friable i.e. easily crumbled or pulverized 
to the touch [26].  
 
Figure 3: Left: Atlantic salmon parr with acute IPN. The liver is very pale and there are 
punctuate haemorrhages over the hyperemic pancreatic area [26]. Right: Rainbow trout with 
IPN. The intestine is grossly distended due to undigested food [3] 
 
1.3.4: Vaccines against IPNV   
Although there are some commercial vaccines available against IPNV, the disease still 
continues to be a major problem with frequent outbreaks in farmed salmon fry and post-
smolts and in modern aquaculture worldwide. Although some experimental vaccines have 
been developed so far, only a few have been commercialized, and the protective effects 
against IPNV demonstrated in laboratory trials are not consistent with field observations. This 
may be attributed to the lack of effective challenge models for evaluating the efficacy of IPN 
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vaccines under experimental conditions. Overall, challenge models should produce very high 
mortality in unvaccinated fish in order to demonstrate the abilities of vaccines to confer 
protective immunity by reducing mortality in vaccinated fish compared to unvaccinated fish 
after exposure to challenge virus [31]. Moreover, most vaccine efficacy tests are based on 
determining the post challenge relative per-cent of survival (RPS) as a measure of protection 
[31]. Data obtained from these studies do not show the ability of vaccine-induced immune 
responses to prevent the establishment of infection. Although antibody titers have been 
reported alongside relative percent survival values in fish, they have not been linked to 
functional aspects of disease protection. It is not clear whether antibodies produced against 
IPNV prevent establishment of infection, block dissemination of virus to target organs or 
reduce replication of virus in target organs in order to prevent establishment of pathological 
disease [31]. Hence the exact mode of action of vaccine induced protection against IPNV has 
not been clearly defined. Another confounding factor in IPNV vaccinology, is the ability of 
the virus to express different variant strains based on amino acid differences within the 
immunogenic domain of the VP2 capsid [31, 32]. 
 Almost all the salmon farmed in Norway is vaccinated against IPN. The current vaccines 
probably contribute to a reduced number of outbreaks, but do not prevent infected fish from 
being asymptomatic carriers of the virus for a long time, thus giving subsequent risk for new 
outbreaks [3, 28]. One of the reasons why early attempts of vaccination to IPNV had not 
fulfilled many of their expected beneficial effects, might be because the highest susceptibility 
to IPNV infection occurs at the early stage when fish are not immunocompetent [8]. There are 
currently 4 vaccine manufacturers that offer IPNV vaccines. Current commercial vaccines are 
all oil-adjuvanted i.p. injection vaccines. Pharmaq AS, Aqua Health Novartis and Centrovet 
produce mono or multi-valent vaccines containing inactivated IPNV, and Intervet Norbio 
Norwax® Protect-IPN uses a VP2 protein fragment expressed in E. coli [8]. 
As pointed out by Gomez-Casado et al. [8] that because of the limited efficacy of these 
vaccines in the field and the presence of tissue adhesion caused by intraperitoneal injection of 
the oil-adjuvants, alternative vaccines using different antigen delivery systems are needed. 
Besides, the cost of producing inactivated vaccines is high because it requires cultivation of 
viruses in bulk followed by inactivation procedures that require proficient safety tests [31].     
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1.4: RIG and MAVS, the RLR-signaling pathway 
 
The innate immune system is the first line of defense against infectious pathogens and is 
especially critical for the teleost fish as the adaptive immune response is not as specific as the 
mammalian system. The innate immune system responds to pathogens by activating host 
defense mechanisms via interferon and inflammatory cytokine expression. Pathogen 
associated molecular patterns (PAMPs) are sensed by pattern recognition receptors (PRRs) 
which are expressed on a variety of different cell types. PAMPs are broadly conserved 
chemical or structural features present in pathogens but not host cells, thereby serving as alert 
signals to the innate immune system of the host. PAMPs include viral RNA, cytoplasmic 
DNA, prokaryotic nucleotide second messengers, and bacterial cell wall components like LPS 
or flagellar proteins. To date, three families of PRRs, inclunding Toll-like receptors (TLRs), 
retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) and nucleotide-binding 
oligomerization domain (NOD)-like receptors (NLRs), have been identified for their 
indispensable role in pathogen recognition and triggering of the antipathogen immune 
response.  
In this thesis the focus was directed towards RIG-I also known as DDX58, which belongs to 
the RLR-family. This family of receptors is ATP dependent helicases that sense the presence 
of viral RNA in the cytoplasm of host cells [21]. Members of this family includes RIG-I, 
MDA5 and LPG2. RIG-I predominantly senses viral RNA containing a 5’triphosphate along 
with dsRNA regions [21]. This is a perfectly sound target as free 5’-triphosphate RNA end are 
absent from eukaryotic cytoplasm due to RNA metabolism in the nucleus e.g. mRNA 
capping. Several ligands has also been identified, like short poly(I:C), and the panhandle 
structure formed by the 5’ and 3’ ends of negative-sense RNA genomes [33].  
A characteristic feature of RLRs which belong to superfamily 2 (SF2) helicases/ATPases, is 
an ATPase domain. Besides the characteristic SF2 domain, RIG-I also possess two N-
terminally located caspase activation and recruitment domains ( CARDs) and a C-terminal 
RD also termed the C-terminal domain [21]. The CARDs are involved in downstream 
signaling, while the RD is a major pattern recognition site and senses preferentially dsRNA 
blunt ends with 5’-triphosphates.  
Upon activation by PAMPs, RIG-I associate with the adaptor protein mitochondrial signaling 
protein MAVS located at the outer mitochondrial membranes. This adaptor molecule working 
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downstream of MDA-5 and RIG-I, was found in 2005 at almost the same time by four 
independent labs [34]. MAVS is encoded in the nuclear genome and not in the mitochondrial 
DNA and is expressed ubiquitously in a variety of tissues and cell types. MAVS also possess 
an N-terminal CARD [21, 34]. The interaction of the CARDs of RIG-I with MAVS (also 
called IPS1, VISA, and CARDIF) results in the activation of intracellular signaling cascades, 
although the mechanism underlying MAVS activation is not understood. When viral RNA is 
detected it ultimately leads to the activation of the serine/threonine kinases IKKα/β and IKK-
i/TBK-1, involving dimer formation of MAVS. IKKα/β then phosphorylates NF-кB, which 
then translocates to the nucleus to activate its target genes. IKK-i/TBK-1 phosphorylates IRF3 
and IRF7, which then dimerizes, translocates to the nucleus and trigger the expression of type 
I interferons [21]. The type I interferons are cytokines that function in an autocrine and 
paracrine manner to activate transcription via IFN-stimulated response elements up-stream of 
ISGs (Interferon stimulated genes). The activation of type I interferons then triggers the 
expression of ISGs. Secreted type I interferons can activate the JAK/STAT pathway in self 
and neighboring cells, resulting in the upregulation and production of a large number of 
antiviral genes, including RIG-I/MDA-5, RNA-dependent protein kinase (PKR), 2’,5’- 
oligoadenylate synthetase (OAS), and major histocompatibility complex (MHC) class I 
molecules [33]. Still one should keep in mind that fish interferons are not true homologs of 
mammalian type I interferons, but their expression is activated by a similar regulatory 
mechanism, which has occurred independently in fish and mammals probably by a process of 
convergent evolution. 
Simply put; upon RNA viral infection, the RNA helicases RIG-I and MDA-5 recognize virus-
derived RNA ligands, leading to auto-activation by its drastic conformational changes [34], 
and they translocate to the outer mitochondrial membrane to interact with MAVS. A previous 
study revealed that MAVS dimerization through its transmembrane domain is essential for 
activating NF-κB and IRF-3, and suggested that RIG-I-MAVS interaction induced the MAVS 
dimers [35]. 
RIG-I is constitutively expressed, albeit at low levels, and their expression is enhanced by 
activation of IFN-α/β signaling. In the absence of activators, RIG-I exist in an inactive 
conformation, which prevents effector access to the N-terminal CARDs and the helicase 
domain [33]. The transition from the inactive conformation to an active conformation 
facilitates interactions between the CARDs of RIG-I and MAVS [33]. 
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Many accessory proteins have been identified that play a critical role in mediating the 
downstream signaling triggered by RLRs, including MAVS, TRIM25 (tripartite motif-
containing 25), STING (stimulator of IFN gene, also known as MITA and ERIS) and EYA4 
(eyes absent 4) in mammalian cells [36]. MAVS is a critical adaptor for RIG-I, MDA5 and 
NOD2 signaling, mediating the activation of IRF3 and the subsequent production of type I 
IFNs. A very recent study by Hou et. al. [37] demonstrated that the sequential binding of 
RIG-I to viral RNA (5’-ppp RNA) and K63 ubiquitin chains induces the formation of large 
MAVS aggregates, which behave like prions and effectively convert endogenous MAVS into 
functional aggregates with a potent ability to activate NF-κB and IRF3. The authors suggest 
that a prion-like conformational switch occurs in MAVS that activates and amplifies antiviral 
responses and provides a mechanism to mediate robust antiviral responses. Based on their 
results, the authors proposed a model of MAVS activation that involves the following steps: 
(1) RIG-I binds to viral RNA through the C-terminal RD domain and the helicase domain; (2) 
RIG-I hydrolyzes ATP, undergoes a conformational change, and forms a dimer that exposes 
the N-terminal CARD domains; (3) the CARD domains recruit TRIM25 and other 
ubiquitination enzymes to synthesize unanchored K63 polyubiquitin chains, which bind to the 
CARD domains; (4) the ubiquitin-bound CARD domains of RIG-I interact with the CARD 
domain of MAVS, which is anchored to the mitochondrial outer membrane through its C-
terminal TM domain; (5) the CARD domain of MAVS rapidly forms prion-like aggregates, 
which convert other MAVS molecules into aggregates in a highly processive manner; (6) the 
large MAVS aggregates interact with cytosolic signaling proteins, such as TRAFs, resulting 
in the activation of IKK and TBK1 [37]. 
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Figure 4: A model of MAVS activation involving a prion-like conformational switch induced 
by RIG-I [37] 
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Figure 5: Overview of the RLR pathway [34] 
 
 
Figure 6: Phylogenetic tree of vertebrate CARDs from RIG-I, MDA5, and MAVS [38] 
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1.5: Target genes 
The relative gene expression of various target genes in ASK and CHSE-214 cells were 
investigated to see how the relative gene expression would respond to different treatments 
like transfection with the RIG- or MAVS-plasmid, infection with IPNV or ISAV and poly 
I:C-stimulation. Several of the genes used as targets in this thesis, were chosen as they are 
part of the innate immune signaling and response, and would be relevant to examine.  
1.5.1: Mx 
One of the target genes chosen is Mx (Myxovirus resistance protein). Mx was the first ISG to 
be studied in fish in relation to virus infection, and has since become a major molecular 
marker for both viral infection and IFN induction in salmonids and other fish species [39]. Mx 
is an antiviral protein, but at present time, still very little is known on the inherent ability of 
teleost Mx protein to prevent viral replication. However, it has been hypothesized that Mx 
proteins prevent viral replication by preventing intracellular trafficking of viral nucleocapsids 
[40]. It has previously been shown that over expression of the Mx gene can provide different 
levels of resistance to IPNV and ISAV in CHSE-cells [41]. Mx is a member of the dynamin 
superfamily of large GTPase and thus has the ability to self-assemble. The Mx gene is 
induced by the type I interferon (IFN) the main cytokine regulating innate immune responses 
directed towards viruses and accumulates in the cytoplasm of IFN-treated cells, associating 
partly with the endoplasmic reticulum [41].   
1.5.2: ISG-15 
ISG-15 is one of the IFN-stimulated genes that contain ubiquitinlike domains. This protein is 
up-regulated early and becomes conjugated to diverse cellular proteins upon IFN stimuli [42]. 
ISG-15 homologs have been identified in crucian carp, goldfish, Atlantic salmon and Atlantic 
cod. In Atlantic salmon the 17.3 kDa ISG-15 ortholog increased in expression in response to 
poly I:C stimulation and ISAV infection. This target gene was chosen in this thesis, as a 
previous study has shown that immunoprecipitation of ISAV protein from infected TO-cells 
using an anti-Atlantic salmon ISG-15 antiserum, suggests that ISG-15 has a possible antiviral 
role in ISAV infection of Atlantic salmon [42].   
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1.5.3: IFNa 
Within the innate immune response the type I interferon system is an essential innate antiviral 
component that protects fish from some virus infections by inducing an antiviral state in cells. 
Interferons are widely expressed, inducible and multifunctional cytokines. IFN is secreted by 
the virus-infected cell and transported by the blood stream to alarm other cells in the body, i.e. 
the interferons have both an autocrine and a paracrine effect. The antiviral effect is exerted 
through the binding of IFNa and IFNb to the IFNa/b receptor, which is present on all 
nucleated cells [40]. Viral infection will inevitably trigger induction of IFNs and ISGs in 
vertebrates due to the multitude of immune cells and the many viral sensors in host cells. 
However viruses have developed various mechanisms to antagonize and counteract induction 
of these genes, making it a race between replication of the virus and the antiviral response of 
host cells [39].  
 Unlike higher vertebrates teleosts do not have red bone marrow or lymph nodes as a primary 
and secondary lymphoid organs; myelopoieses occurs in the teleost head kidney and/or spleen 
[42]. Type I interferons play a central role in the induction of antiviral responses, as they lead 
to the activation of many interferon-inducible genes, which influence protein synthesis, 
growth arrest, and apoptosis. They also enhance dendritic cell maturation, natural killer cell 
cytotoxicity, and differentiation of virus-specific cytotoxic T lymphocytes, thus providing a 
bridge between innate and adaptive immune responses [42]. Secretion of IFNs results in the 
induction of several hundred IFN-stimulated genes (ISGs), some of which encode antiviral 
proteins such as Mx protein, dsRNA activated protein kinase (PKR) and 2’,5’-oligoadenylate 
synthetase (OAS) [39].   
In contrast to the type I IFNs of birds and mammals, which has no introns, the fish IFNs 
contains 5 exons and 4 introns similar to IFN-γs [40, 42]. In Atlantic salmon there are 11 
clusters of IFN genes recently discovered and classified in to three subtypes (a, b and c) of 
type I interferons, all possessing genes with an intron-exon structure similar to human type II 
interferon (IFN-λ), although their protein sequences are more similar to IFN-α than IFN-λ. 
Atlantic salmon IFNa and IFNb are not orthologs of mammalian IFN-α and IFN-β, but appear 
to utilize similar induction pathways [42]. The Atlantic salmon IFNa is induced in much the 
same way as mammalian IFN-β (via IRF3 and NF-κB), whereas the IFNb of Atlantic salmon 
is induced through a similar pathway as IFN-α in mammals (via IRF7) [42]. The mature 
Atlantic salmon type I IFNs are among the shortest IFNs yet detected [40].   
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Atlantic salmon IFN-α1has in previous studies shown to induce a potent antiviral activity 
against infectious pancreatic necrosis virus in cells, but in contrast it did not protect salmon 
cells against infection by infectious salmon anemia virus, suggesting that ISAV must have 
developed mechanisms to evade the antiviral effects of IFNs, making IFNa an interesting 
target gene in this thesis [39].      
1.5.4: TNF-α 
Tumor necrosis factor-α (TNF-α) is an inflammatory cytokine that produces a local state of 
inflammation. TNF mediates most of its pro-inflammatory effects by binding to TNF receptor 
I (TNF-R1). TNF-R1 is a type I transmembrane protein that has cysteine-rich extracellular 
domains (CRDs) for TNF binding. Its cytoplasmic tail contains a death domain (DD) that 
recruits the DD-containing adaptor TRADD and kinase RIP1. TRADD facilitates binding of 
RIP1 to TNF-R1 and recruits TRAF2, which is an adaptor for the ubiquitin ligases cIAP1 and 
cIAP2 which all contribute to NF-κB and MAPK activation, but the details of how they do so 
continue to be unraveled [43]. The TNF-α is released mainly by macrophages (but can be 
produced by other cell types as well) as a result of Toll-like receptor stimulation, and can 
have both beneficial and harmful consequences [44]. In response to TNF-α, vascular 
endothelial cells make platelet-activating factor, which triggers blood clotting and blockage of 
the local blood vessels. This restricts the leakage of plasma from the blood and prevents 
pathogens from entering the blood and disseminating infection throughout the organism [44]. 
This cytokine is also involved in apoptosis (programmed cell death). This gene was chosen as 
a target gene to investigate whether the expression of this inflammatory cytokine is up-
regulated or down-regulated during infection with IPNV and ISAV.   
1.5.5: IL-1β 
Concerning the inflammatory reaction, interleukin 1β (IL1β) is one of the best characterized 
pro-inflammatory cytokines often used as marker of an activated inflammatory response and 
was for this reason chosen as a target gene in this thesis. Induction of the cytokine IL-1β by 
PRRs serves to amplify the inflammatory response because it promotes NF-κB and MAPK 
activation. Binding of IL1β to IL1R triggers MyD88-dependent signaling [43].    
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1.5.6: GRP78  
Although a protein chain can fold into its correct conformation without outside help, protein 
folding in a living cell is generally assisted by special proteins called molecular chaperones. 
These proteins bind to partly folded chains and help them to fold along the most energetically 
favorable pathway, thus making the folding process more efficient and reliable [45]. The gene 
encoding GRP78 also known as BiP was chosen as target gene as it has previously been 
described that the gene encoding glucose-regulated protein 78kDa (GRP78) has been found to 
be increased in expression following heat shock in rainbow trout cell line RTG-2 indicating 
its role as a heat shock protein. Viruses rely on the utilization of cellular machinery and 
resource to complete their life cycle. In this complex process, viruses produce double-
stranded RNA intermediates that trigger interferon responses, while viral polypeptides 
synthesized during infection stimulate ER stress [46]. Several mammalian viruses are also 
potent inducers of this GRP78 transcript via the ER stress pathway [46] and prolonged ER 
stress triggers apoptosis (programmed cell death). This molecular chaperone protein is located 
in the lumen of the endoplasmatic reticulum (ER) and binds newly synthesized proteins as 
they are translocated into the ER, to aid in correct folding and oligomerization of these 
proteins. In addition to being a chaperone protein it is also implicated in the immune 
response. The mRNA is upregulated by bacterial infection in Atlantic salmon, is involved in 
macrophage development in goldfish, and in differentiation of murine myeloid leukaemia 
cells into macrophages by the proinflammatory cytokine IL-6 [47]. This protein also 
possesses an anti-apototic function as it can protect the cell against cell death caused by 
disturbance of ER homeostasis [48]. As a processing plant for folding and post-translational 
modifications of proteins, the ER is an essential organelle for viral replication and maturation. 
In the course of productive infection, a large amount of viral proteins are synthesized in 
infected cells, where unfolded or misfolded proteins activate the ER stress response [46]. It 
has been suggested that in mammalian cells the ER chaperone GRP78 works as a master 
control interacting with three mediators: PKR-like ER kinase (PERK), activating transcription 
factor 6 (ATF6) and the ER transmembrane protein kinase/endoribonuclease (IRE1) [46]. In 
response to ER stress, these components function to reduce the levels of new proteins 
translocated into the ER lumen, to enhance the protein-folding capacity and secretion 
potential of the ER, and to facilitate transport and degradation of ER-localized proteins [46]. 
As a resident of the ER chaperone, the expression of GRP78 is upregulated in response to ER 
stress in the cells. For this reason the GRP78 was chosen as a target gene to investigate 
whether the IPNV or ISAV would induce ER stress in the cell lines used. Although virus-
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mediated apoptosis in ER stress has been recognized, the biological significance of such a 
process is not well defined [46].  
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2: Materials  
 
Table 2: Kits 
  
High-capacity RNA-to-cDNA synthesis kit Applied Biosystems, Warrington, UK 
RNeasy® Mini Kit Qiagen, MD, USA 
RNeasy® Midi Kit Qiagen, MD, USA 
Pierce® BCA protein assay kit Thermo Fisher Scientific, Rockford, USA 
Qiagen Plasmid Midi kit Qiagen, MD, USA 
Amaxa® Cell Line Nucleofector® Kit T Amaxa Biosystems, Cologne, Germany 
 
Table 3: Reagents 
  
Ampicillin Sigma Aldrich, St. Louis, USA 
β-mercaptoethanol Gibco BRL, Uxbridge, UK 
Crystal Violet Sigma Aldrich, St. Louis, USA 
Dry milk Normilk AS, Norway 
Ethanol Arcus, Oslo, Norway 
FCS, Fetal calf serum Gibco-Invitrogen, Paisley, UK 
Gentamicin Cambrex Bio Sciences, Verviers, Belgium 
HCl Merck, Darmstadt, Germany 
KCl Merck, Darmstadt, Germany 
KH2CO4 Merck, Darmstadt, Germany 
Laemmli sample buffer Bio-Rad Laboratories, CA, USA 
Leibowitz L-15 medium Cambrex Bio Sciences, Verviers, Belgium 
L-glutamine Cambrex Bio Sciences, Verviers, Belgium 
Methanol Arcus, Oslo, Norway 
NaCl Merck, Darmstadt, Germany 
Na2HPO4 Merck, Darmstadt, Germany 
SYBR®Green Applied Biosystems, Warrington, UK 
Trypsin-EDTA Gibco BRL, Uxbridge, UK 
 
Table 4: Cell lines used in this thesis 
ASK-cells 
CHSE-214-cells 
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Table 5: Taxonomic information of the viruses used in this thesis 
Full name Family Genus genome Strain 
Infectious Pancreatic Necrosis Virus Birnaviridae Aquabirnavirus dsRNA 
 V1244, 
Sp 
Infectious Salmon Anemia Virus Orthomyxoviridae Isavirus ssRNA Neg ISAV4 
 
Table 6: Medium used to maintain both ASK- and CHSE-cells 
Leibowitz L-15-medium  
Supplemented to final concentration with  
50 μg/ml gentamicin  
4 mM L-glutamine  
40 μM β-mercaptoethanol  
10% fetal calf serum  
 
Table 7: Crystal violet staining solution 1 litre 
  
Reagents Quantity End concentration 
Crystal violet 0,5 g 0,05 % w/v 
37 % formaldehyde 27 ml 1 % 
10X PBS 100 ml 1X 
Methanol 10 ml 1 % 
dH2O ad 1000ml ≈863 ml   
 
Table 8: 1X RIPA-buffer 
RIPA-buffer is used to lyse cells and tissues 
  
20 mM Tris-HCl (pH 7.5)  
150 mM NaCl 
1 mM Na2EDTA 
1 mM EGTA 
1 % NP-40 
1 % sodium deoxycholate 
1 tablet of the proteaseinhibitor Complete® from Roche dissolved in 1 ml PBS 
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Table 9: Composition of the buffers used for plasmid preparation 
Buffer Composition 
Buffer P1 
(resuspension buffer) 
 
50mM Tris-Cl; pH:8.0, 10mM EDTA, 
 100µg/ml Rnase A 
Buffer P2 (lysis buffer) 
 
200mM NaOH, 1% SDS (w/v) 
 
Buffer P3 
(neutralization buffer) 
 
3,0 M potassium acetate, pH 5,5 
Buffer QBT 
(equilibration buffer) 
 
750mM NaCl, 50mM MOPS pH 7,0, 
 15% isopropanol (v/v), 0,15% Triton X-100 (v/v)  
Buffer QC (wash 
buffer) 
 
1,0mM NaCl, 50mM MOPS pH 7,0, 
15% isopropanol (v/v) 
Buffer QF (elution 
buffer) 
 
1,25mM NaCl, 50mM Tris-Cl pH 8,5,  
15% isopropanol (v/v) 
TE 
 
10mM Tris-Cl pH 8,0, 1mM EDTA 
 
Table 10: Phosphate buffered saline (PBS) 4L 
Reagent Amount 
NaCl 32 g 
KCl 0,8 g 
KH2PO4 1,08 g 
Na2HPO4*2H2O 7,12 g 
MQ 3950 ml 
    
pH is adjusted to 7,4 with NaOH/HCl   
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Table 11: Characteristics of real-time PCR primers used in this thesis 
Gene 
target 
Directio
n Primer Sequence Acc. No. 
Amplico
n size 
(bp) E-value 
18S rRNA Forward TGTGCCGCTAGAGGTGAAATT AJ427629 
61 2 
  Reverse GCAAATGCTTTCGCTTTCG   
EF1α Forward 
CACCACCGGCCATCTGATCTACA
A AF321836 
77 1,97 
  Reverse 
TCAGCAGCCTCCTTCTCGAACTT
C   
Mx3 Forward 
TGATCGATAAAGTGACTGCATTC
A SSU66477 80 2 
  Reverse TGAGACGAACTCCGCTTTTTCA   
IFNα2 Forward CCTGCCATGAAACCTGAGAAGA AY216594 
107 2 
  Reverse TTTCCTGATGAGCTCCCATGC   
TNFα Forward CGGGTTCAAGCTACAAGGGA DQ787158 
51 2,21 
  Reverse AAGAGCCCAGTGTGTGGGAT   
Il1β Forward GGAGAGGTTAAAGGGTGGCG AY617117 
51 2,06 
  Reverse TCCTTGAACTCGGTTCCCAT   
GRP78 Forward  ACGGCATCTTGCGCGTCACA   
254   2 
  Reverse  CAGCTTGCCGCCCAGCTTCT 
NM_001141642 
 
ISG15 Forward TGTTAGGTGTCAATGGGAGCAA AY926456 
151 2,03 
  Reverse TGTGTCTGGCCCTTTTCGTT   
ISAV 
seg7 Forward 
GAAATGGACAGAGACGGCGTAT
CA AY044132 123 2,05 
  Reverse GCTCAACTCCAGCTCTCTCATTGT   
IPNV ipna Forward  TACCAATCTGCGGTCTCGAC   
 109  2 
  Reverse TGTGTTTCGCACCTCCTCG  U48225 
ssMAVS Forward AGGAGGTGCTGCACAATGTTGCT   
 95  2 
  Reverse GGCGTCTGGCCGTCGTTGT  FN178458 
ssRIG-I Forward TACTGATCGGGAGAGGACACA   
60  1,83 
  Reverse AGTTCAGCGTCATGCGTGT 
NM_001163699 
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3: Methods 
3.1: Propagation of ISAV4 and IPN virus 
The same protocol was used for propagation of both ISAV4 and IPNV, but with IPNV fewer 
days were needed before complete CPE could be observed. 
Protocol: 
1) ASK-cells were grown in 3-layer incubator flasks in 20°C to 70-80% confluence. The 
medium was removed, before the ISAV4-inoculate subsequently were poured over the 
cells together with Leibowitz L-15 medium without serum, to just barely cover the 
growth surface. The reason for not using medium with serum is that serum may 
contain glycoproteins that may compete with the ISA-virus for binding to ASK-cells.  
2) The incubator flasks with cells and virus inoculate were placed on a “belly-dancer” for 
4 hours in 13°C for the virus to adhere to the cells. 
3) The virus inoculate was then removed from the cells and stored in -20°C for later use. 
4) Leibowitz L-15-medium with above mentioned additives (see Table 6) was transferred 
back to the incubator flasks.   
5) The ASK-cells were then incubated at 13°C until total CPE could be observed when 
investigating cells in the microscope, i.e. the cells were rounded up and did no longer 
adhere to the incubator flask. CPE was induced earlier with the IPNV (≈4-6 days) 
compared to ISAV4 (≈10 days). 
6) The media with the virus-killed cells and virus were transferred to plastic centrifuge 
containers and centrifuged for 20 min at 4000g in 15°C. This first centrifuge step was 
performed to pellet down the cell debris, so that the supernatant would mostly consist 
of virus particles. The supernatant was then transferred to an Erlenmeyer flask. 
7) The supernatant were divided into 6 centrifuge tubes and centrifuged on a Spin rotor® 
for 2 hours at 4°C at 29 500 rpm (100 000 x g) to centrifuge down the virus particles. 
This step was performed twice i.e. for 4 hours in total.  
8) The supernatant was then discarded, and the virus pellet was resuspended in 2 ml of 
PBS by putting the tubes on a shaking-machine in an incubator at 4°C over night. 
9) The virus suspension from the 6 corning-tubes was then combined to 1 tube and 
centrifuged for 2 hours at 29 500 rpm, 4°C to clear out any last cell residual 
contamination.     
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3.2: Cell lines 
3.2.1: ASK-cells 
ASK-cells (Atlantic salmon kidney cells) were kindly provided by B. Krossøy (Department of 
Fisheries and Marine Biology, University of Bergen, Norway). This cell line was obtained in 
1998 from cells taken from the normal kidney of an adult female Atlantic salmon. This cell 
line is macrophage-like, adherent, grows in a mono layer, and is epithelial in morphology. 
This cell line has previously been shown to be permissive for propagating both IPNV and 
ISAV [49].  
  
Figure 7: Left: ASK-cells Right: CHSE-cells. 40X magnification 
3.2.2: CHSE-214 cells 
CHSE-cells (Chinook salmon embryo cells) are also an adherent cell line that grows in a 
mono layer. These cells were obtained from Oncorhynchus tshawytscha, Chinook salmon, 
and are susceptible to a variety of different fish viruses [50]. These cells have a fibroblast-like 
morphology. This cell line was included in this study due to their higher transfection 
efficiency than ASK-cells.   
3.3: Cell maintenance 
Both ASK-cells and CHSE-cells were maintained at 20°C, routinely split once a week and 
cultured in Leibowitz L-15 medium supplemented as described in Table 6. Even though the 
same media was used for both cell lines, separate flasks were used to prevent cross 
contamination of the cell lines. For the same reason, the two different cell lines were 
preferably split on different days if possible. The cell lines were split by using a trypsin-
EDTA combination product from Gibco. Cell-cell adhesion in tissues is mediated by a variety 
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of homotypic interacting glycopeptides called CAMs some of which are calcium dependent 
e.g. cadherins. These would be sensitive to the chelating effects of EDTA [51]. 
Protocol used for splitting cells: 
1) The medium was removed from the incubator flask and transferred to an Erlenmeyer 
flask. 
2) The cells were washed 3 times with 5 ml PBS. 
3) Cells were then trypsinized with either 1 or 2 ml 0.05 % Trypsin-EDTA (1 ml for 
ASK-cells, 2 ml for CHSE-cells respectively since CHSE-cells were more adherent 
than ASK-cells), and observed in light microscope to see when the cells were 
detached. The incubator flask was tapped carefully to make cells successfully detach 
from the plastic.  
4) Some of the medium removed at the start was then transferred back to the incubator 
flask so that the serum in the culture medium could neutralize any residual activity of 
the trypsin.  
5) The cells split 1:2 i.e. half the volume of cell suspension was either discarded or used 
for different experiments and the incubator flask was then refilled with medium up to 
50 ml.  
6) The incubator flasks were then put back for incubation at 20°C.  
3.4: Plasmid preparation 
Plasmids were prepared with the QIAGEN Plasmid Midi kit where all the buffers were 
supplied. The buffers used and their composition is described in Table 9. 
3.4.1: Obtaining single cell colonies with transformed E.coli 
 
Bacterial culture streaking allows bacteria to reproduce on a culture medium in a controlled 
environment. The bacteria is spread across an agar plate and allowed to incubate at a fitting 
temperature over a period of time. This method is useful for isolating pure bacterial colonies 
from a mixed population, in this case a population consisting of transformed and non-
transformed E.coli. Transformation is in this thesis defined as cells that has successfully taken 
up naked DNA and that are expressing the selection marker coded for in the plasmid.  
1) 200 ml of LBA-medium was melted in the micro oven until reaching a clear and 
liquid. 100 ml was transferred into two separate and autoclaved Erlenmeyer flasks. 
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2) The LBA-medium was allowed to cool down, before 100 µL kanamycin and 
ampicillin with a concentration of 50 mg/ml, was added to their respective Erlenmeyer 
flask (final concentration 50µg/ml). 
3) The LBA-medium with antibiotics was poured over in petri dishes with approximately 
25 ml in each dish. 
4) When the agarose dishes were set, E.coli transformed with plasmids containing either 
RIG-I, MAVS, RIG-GFP og MAVS-GFP-inserts was streaked gently over the dishes 
with a plastic inoculation loop over the top end of the agar plate moving in a zig-zag 
horizontal pattern until 1/3 of the plate is covered. The plate is then rotated about 60° 
and with a new inoculation loop the bacteria are spread from the end of the first streak 
to a second area with the same pattern. The plate is rotated yet again and bacteria are 
streaked from the end of the second are to a third area. The GFP-plasmids contain a 
kanamycin-resistance gene that confers resistance to the transformed bacteria allowing 
them to grow on the agarose dishes with kanamycin. The plasmids containing the 
RIG-I and MAVS inserts confers ampicillin-resistance to the transformed E. coli 
bacteria allowing them to grow on the agarose dishes with ampicillin. 
5) The agarose dishes were inverted and then incubated over night at 37°C. 
3.4.2: Making the overnight culture for harvesting transformed E.Coli: 
 
6) The following day four 250 ml Erlenmeyer flasks were filled with 100 ml room 
tempered LB-medium in each flask. Ampicillin was added to the two flasks that were 
to be incubated with the RIG and MAVS-transformed bacteria, and kanamycin to the 
two flasks that were to be incubated with the GFP-plasmid transformed bacteria. The 
antibiotics were added to an end concentration of 30µg/ml. 
7) Sterile plastic inoculation loops were used to transfer single colonies to each tube: one 
with pRIG-I, pRIG-GFP, pMAVS, and p-MAVS-GFP. 
8) The Erlenmeyer flasks were incubated at 37°C in a shaking incubator over night. 
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3.4.3: The plasmid preparation: 
 
9) The following day the bacteria suspension in the Erlenmeyer flasks were transferred to 
250 ml centrifuge flasks and pelleted at 6000 x g for 15 minutes at 4°C on a 
Beckmann centrifuge. 
10)  The centrifuge flasks were decanted carefully to discard the supernatant. The pellet 
was then resuspended in 6 ml buffer P1 added LyseBlue until a homogenous 
resuspension was obtained.  
11) 6 ml buffer P2 was then added to the suspension. Inverted 4-6 times and then 
incubated at room temperature for 5 minutes. The solution should now turn blue. 
12)  Caps were attached to the nozzle of the Qiafilter midi cartridges. 
13)  6 ml of buffer P3 pre chilled to 4°C was added to the cell lysate and mixed by 
inversion until all the blue color from the LyseBlue in buffer P1 mixed with buffer P2 
had disappeared and a white fluffy flocculate has appeared. This indicates that the 
chromosomal DNA and proteins have efficiently been precipitated, while keeping 
plasmid DNA in solution.  
14) The lysate is then transferred to barrel of the Qiafilter cartridge and the cartridge is 
then incubated at room temperature for 10 minutes without inserting the plunger.  
15)  A HiSpeed midi tip column was prepared by adding 4 ml buffer QBT to the column 
and letting the buffer sieve through by gravitation. 
16)  The lysate from the Qiafilter cartridge is then filtrated over into the previously 
prepared HiSpeed midi tip column by removing the cap from the outlet nozzle and 
inserting the plunger gently. 
17)  The HiSpeed midi tip column was then washed with 20 ml buffer QC. The flow 
through was discarded. 
18)  The DNA was eluated with 5 ml buffer QF. 
19)  The DNA was then precipitated by mixing it with 3.5 ml room temperature 
isopropanol and allowing it to incubate at room temperature for 5 minutes to minimize 
salt precipitation. 
20)  During the incubation, the plunger from a 20 ml syringe was removed and a 
QIAprecipitator Midi Module was attached to the outlet nozzle of the syringe.  
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21) The QIAprecipitator Midi Module was then placed over a waste bottle and the 
eluate/isopropanol mixture was transferred to the barrel of the syringe. The plunger 
was gently inserted and the mixture was filtered by exerting constant pressure on the 
plunger. 
22)  The QIAprecipitator Midi Module was removed, and the plunger pulled out before 
the QIAprecipitator Midi Module was reattached. 2 ml of 70% ethanol was added to 
the syringe. The DNA was washed by inserting the plunger and pressing the ethanol 
through the QIAprecipitator Midi Module.  
23) The QIAprecipitator Midi Module was removed, the plunger pulled out, and the 
QIAprecipitator Midi Module was reattached. The plunger was reinserted and the 
membrane was dried by pressing air through the membrane. This step was performed 
twice. 
24) The outlet nozzle of the QIAprecipitator was dried with some absorbent paper to 
prevent ethanol carryover. 
25)  The plunger from a new 5 ml syringe was removed and the QIAprecipitator was 
attached to the outlet nozzle of the syringe. The outlet of the QIAprecipitator Midi 
Module was held over a 1.5 ml collection tube. 1 ml buffer TE was added to the 
syringe, and the DNA was eluted by inserting the plunger and exerting constant 
pressure.  
26) The QIAprecipitator was removed, the plunger pulled out, the QIAprecipitator 
reattached and the eluate from step 25 was transferred back to the syringe and then 
eluted for the second time into the same collection tube. 
3.4.4: PicoDrop measurement of the plasmid preps: 
 
27) The plasmid preps were then measured with a PicoDrop 100™ to determine the 
concentration and the purity by using the PicoDrop-pipette to draw 2µl of sample up 
in the disposable UVpette pipette tips that allows UV/Vis measurements to be taken 
directly through the pipette tip. The 260/280 nm ratio for all preps in this thesis were 
from 1.90 to 2.20.  
28) The plasmid preps were then stored at -20°C until further use. 
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Figure 8: The patented UVpette from PicoDrop  
                
3.5: Plasmids 
 
In this thesis, plasmids with Atlantic salmon (Salmo Salar) RIG-I, MAVS, and RIG-I-GFP 
and MAVS-GFP inserts were used to transfect the cell lines ASK and CHSE-214. The GFP-
plasmids are the vectors peGFP-C1 from Clontech, whilst the vectors for the non-GFP 
plasmids were the pcDNA 1/1 Amp vectors from Invitrogen. Both plasmids contain the 
cytomegalovirus immediate-early promoter (CMV) driving constitutive expression. These 
plasmids were kindly provided by Dr. Stéphane Biacchesi, Unité de Virologie et 
d’Immunologie Moléculaires, INRA, CRJ in France [38]. The full sequence for the plasmids 
is provided in the appendices.  
The discovery of green fluorescent protein revolutionized the study of cell biology, protein 
expression and subcellular localization. The gene coding for this protein was isolated from the 
jellyfish Aequora Victoria and is a convenient reporter for monitoring transcription and 
translation, because it is directly visible in living cells without the need for fixation, 
substrates, or coenzymes [5]. Here the plasmids contain our insert (ssRIG-I or ssMAVS) 
fused together with the GFP. Many proteins retain their functions when fused with green 
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fluorescent protein, which permits the study of subcellular location of proteins. In this thesis 
this fact was exploited to study the subcellular location of RIG-I and MAVS in transfected 
cells before and after infection. Transfections with the non-GFP plasmids were done to 
investigate if the over expression of RIG-I or MAVS-protein in the cell would confer any 
protection of the cells towards the ISA virus or the IPN virus. 
 
Figure 9: The pcDNA-1-RIG-I plasmid 
 In Figure 9 above the structure of the full length RIG-I plasmid is shown. The plasmids were 
visualized by pasting the plasmid sequence into the software SerialCloner version 2.1 (free 
downloadable software), where the sequence was circularized and the insert and particular 
sites were tagged. The RIG-I insert is 2934 nucleotides long from position 3019-5953. The 
pcDNA1.1/Amp vector uses the ampicillin resistance gene as a selective marker allowing us 
to select only the E. Coli bacterias that were successfully transformed with the plasmid. In 
addition the replication origin and restriction enzyme sites are also depicted, as well as the 
position of the RIG-I primers designed and used in this thesis. The pcDNA1.1/Amp plasmid 
from Invitrogen incorporates the strong cytomegalovirus (CMV) enhancer-promoter sequence 
for high-level expression, and SV40 and polyoma origins of replication to facilitate episomal 
replication, in addition to a T7 primer sequence . Use of the CMV promoter has in previous 
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studies been demonstrated to be the most efficient promoter to drive expression of a plasmid 
in fish cells [54, 55].  
 
Figure 10: The pcDNA-1/1 Amp plasmid with the ssMAVS-insert 
 The ssMAVS-insert is 1821 nucleotides long from position 3019-4840.  
 
Figure 11: The peGFP C1plasmid with the ssMAVS insert 
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In Figure 11 seen above, the GFP-insert holds the position from nucleotide 616-1329 and the 
ssMAVS-insert from position 1360-3181. The peGFP C1 plasmid from Clontech uses 
Kanamycin/Neomycin resistance as a selective marker for the plasmid. 
 
Figure 12: The peGFP C1 plasmid with ssRIG-I (Nter) insert 
The GFP-plasmid with the ssRIG-I insert does not contain the full-length ssRIG-I, only the N-
terminal end of this gene. This insert is 912 nucleotides long holding the position 1360-2272 
in the plasmid.  
The peGFP-C1 plasmids from Clontech are under control of a CMV-promoter. peGFP-C1 
encodes a red-shifted variant of wild-type GFP which has been optimized for brighter 
fluorescence and higher expression in mammalian cells and gives an enhanced green 
fluorescence i.e. eGFP. Genes cloned into the MCS will be expressed as fusions to the C-
terminus of eGFP if they are in the same reading frame as eGFP and there are no intervening 
stop codons . 
The overexpression of RIG-I and MAVS in salmon is interesting to study, as the 
understanding of how these two PRRs can offer protection of the host, offers the possibility of 
novel vaccines. RIG-I and MAVS are critical determinants required for innate immune 
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activation in response to viral infection, and agonists that activate these signaling pathways 
have a potential application as new-generation adjuvants [57]. For use in a licensed vaccine, 
innate immune agonists would preferably not be an endogenous protein that could potentially 
induce autoimmune responses. Ideally, these agonists would also not themselves induce 
adaptive immune response since this would limit repeat usage as well as generate variable 
results in a population due to attenuated responses in individuals with prior exposure. An 
RNA-based innate immune agonist would meet these criteria [58].  
Since plasmid vectors are already TLR9 and cytoplasmic DNA receptor agonists, 
incorporation of RLH ligands into the vector backbone of an antigen-expressing DNA vaccine 
may have targeted immunostimulation application by amplification of type I IFN and 
cytokine production in transfected cells [58]. RIG-I-activating DNA vaccines may have an 
application for improving DNA vaccination for various agricultural applications, especially 
since DNA vaccines have the advantage of ecosafety and being cost effective by using the 
host cell machinery to produce the antigens thereby avoiding the need for bulk propagation 
and purification of viral antigens [31, 58].   
3.6: RNA isolation 
All RNA-isolations performed in this thesis were done with Qiagen RNeasy Mini kit and 
performed according to the manufacturer’s protocol. 
1) The samples were obtained by lysis of adherent cells by addition of RTL buffer to the 
cuture dishes. The samples were stored at -20C° until RNA isolation. The samples 
were thawed and then mixed on a vortex mixer. 
2) 70 % ethanol were added to the samples 1:1, and mixed gently by pipetting up and 
down. 
3) The sample was then transferred to a RNeasy Spin column placed in 2 ml collecting 
tubes. The tube was centrifuged for 15 seconds at 10 000 rpm. Flow through was 
discarded. 
4) 700µl RW1-buffer was added to the column and centrifuged for 15 seconds at 10 000 
rpm. Flow through was discarded. 
5) Added 500µl RPE-buffer to the column and centrifuged for 15 seconds at 10 000 rpm. 
Flow through was discarded. 
6) Added another 500 µl of RPE-buffer to the column and centrifuged for 2 minutes at 
10 000 rpm. Discarded the flow through. 
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7) The RNeasy Spin Column was transferred to a new 2 ml collecting tube and 
centrifuged 10 000 rpm for 1 minute to dry the membrane. 
8) The column was transferred to a new 1.5 ml collecting tube, and added 50 µl RNase 
free water to eluate the RNA. The column was centrifuged for 1 minute at 10 000 rpm. 
9) The samples were stored at -20°C for later cDNA-synthesis. 
3.7: cDNA synthesis 
RNA is prone to cleavage by RNAses leading to degradation. Since cDNA is a 
thermodynamically more stable product, cDNA was directly synthesized from the harvested 
RNA-samples prior to q-PCR where gene expression was to be investigated. cDNA-syntheses 
were performed with High Capacity RNA-to-cDNA pre-dispensed 96-well  reaction plates 
from Applied Biosystems. These 96-well plates are pre-dispensed with 4µl of a 5X master 
mix which contains a mixture of MgCl2, dNTPs, random primers, oligo(dT) primer and 
stabilizers, and a reverse transcriptase. With this master mix 5X formula, RNA is allowed to 
comprise up to 80 % of the reaction mixture. With this method, total RNA isolated from cells 
in this thesis, were reverse transcribed into first strand cDNA. The oligo(dT) primer anneals at 
the polyadenylate tail of the mRNA at the 3´-end and then functions as a primer and a start 
point for the reverse transcriptase, which is a RNA-dependent DNA polymerase isolated from 
a retrovirus, that transcribes the mRNA from the 3´-end to the 5´-end using all the 4 
deoxynucleotide triphosphates producing the first-strand cDNA. These pre-dispensed plates 
also contain random primers which are short random hexanucleotide primers that are 
nonspecific and bind to multiple sites along the mRNA.  
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Figure 13: cDNA synthesis  
Protocol: 
1) RNA-samples were allowed to thaw at room temperature. 
2) 16 µl of the RNA-samples were added to each well, and always in duplicates. 
3) The plate was then centrifuged at 2000 rpm for 2 minutes at 4°C. 
4) After centrifugation, the plate was placed in a thermal cycler from Applied 
Biosystems and run according to the protocol displayed below in Table 12. 
Table 12: Cycling protocol for cDNA synthesis 
5 min 25°C 
30 min 42°C 
5 min 85°C 
∞ 4°C 
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3.8: Quantitative real time polymerase chain reaction (Q-PCR) 
The impact of the PCR upon molecular biology has been profound and it is now the 
touchstone for nucleic acid quantification. The reaction is easily performed, and leads to the 
amplification of specific DNA sequences by an enormous factor making it possible to detect 
minute amounts of DNA [60]. This is also an invaluable method for expression studies in fish 
as there is still a limited availability of antibodies. However the standard PCR does not 
efficiently amplify sequences much longer than about 3kb [60]. Quantitative real-time PCR 
works in essentially the same manner as end-point PCR, i.e. multiple amplification cycles in 
which template DNA is initially denatured, followed by annealing of oligonucleotide primers 
targeting specific sequences, followed by subsequent extension of a complementary strand 
from each annealed primer by a thermo stable DNA polymerase, resulting in an exponential 
increase in amplicon numbers during the PCR. Q-PCR-based analyses combine end-point 
detection PCR with fluorescent detection technologies to record the accumulation of 
amplicons in “real-time” during each cycle of the PCR amplification [61]. In this thesis the 
fluorescent report system used was SYBR Green. Originally one first used ethidium bromide, 
which fluoresce when intercalated into double-stranded DNA, under the development of 
quantitative PCR, but now SYBR Green is a good alternative as it is not as toxic [60]. SYBR 
Green I binds in the minor groove of double-stranded DNA via intercalation between adjacent 
base pairs and when this happens its fluorescence increase over 100-fold [60, 61]. All primers 
used in this thesis varied in length between 15-25 nucleotides and when designing primers a 
high GC content was always preferred since this will increase the specificity of the reaction, 
which is of particular importance for SYBR green assays [61].  
Salmon RIG-I primers were designed using the “ProbeFinder” software from ROCHE, 
(http://www.roche-applied-science.com/sis/rtpcr/upl/index.jsp?id=uplct_030000) by 
pasting in the sequence for ssRIG-I. The salmon RIG-I primers were then ordered from 
Invitrogen. 
In this thesis the transcription activity of the different genes described in Table 11, was 
measured by Q-PCR on samples obtained from ASK-cells that were either IPNV- or ISAV-
infected or RIG-I or MAVS-transfected. Q-PCR was also run on samples obtained from ASK-
cells that had been stimulated with poly I:C as previously described. 
All Q-PCR-experiments followed the same cycling protocol as described in Table 13 below. 
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Table 13: Cycling protocol for Q-PCR 
1 cycle  
pre-incubation  
45 cycles - 
amplification 
1 cycle - melting 
curve 1 cycle - cool down 
95 °C 95 °C 60 °C 72 °C 95 °C 65 °C 97 °C 40 °C 
5 min 10 s 30 s 8 s 5 s 1 min   30 s 
 
3.9: Q-PCR data analysis 
Cycle threshold (Ct) was set automatically by ROCHE Lightcycler® 480 Real Time PCR 
system software for each PCR reaction. High Ct-values were discarded manually. To calculate 
the relative expression of the target genes, Ct-values of target genes and reference genes were 
analyzed using the Relative Expression Software Tool (REST©) [62] which calculates the 
relative expression with the ΔΔCt-method. Q-PCR assays were performed on a LC480 96-
well plate real time PCR machine (Roche, Burgess Hill, UK). The sequences of the primers 
are presented in Table 11. Relative expression of the target genes were normalized against the 
relative expression of the two reference genes elongation factor 1α and 18S. REST also 
compares groups using a pairwise fixed reallocation randomization test to calculate 
differences between groups (2000 randomizations). P< 0.05 was considered significant. 
3.10: Transfection of cells 
In this thesis, transient cell transfection was done with two different methods; the one being a 
liposome-transfection and the other one a transfection performed using electroporation of the 
cells to transfer the plasmids used in this thesis into the ASK- and CHSE-cells. Because fish 
cells have longer cell cycles than mammalian cells and lower optimal temperatures for 
growth, transfection of fish cells generally offers a lower transfection efficiency compared to 
mammalian cells [54], but there has been a lot of research into optimizing the transfection 
efficiency of fish cell lines [54, 55].   
Liposome transfection was generally a more gentle way to transfect the cells, i.e. fewer cells 
died after the transfection, but with this method a lower transfection ratio was obtained 
compared with the method using electroporation. The electroporation gave a higher 
transfection ratio, but also stressed the cells a lot more, and gave fewer viable cells. In 
contrast to lipid-based transfection, where DNA is transferred into the cytoplasm and can only 
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enter the nucleus during mitosis, when the nuclear envelope is disintegrated, nucleofection is 
supposed to deliver DNA into the nucleus independent of cell cycle [55]. 
Liposome transfections were performed using the X-tremeGene HP DNA transfection reagent 
from Roche. This is a low toxicity transfection method which is simple to perform and 
applicable to many cell types that are difficult to transfect by other means. These liposomes 
are phospholipid vesicles, which spontaneously form stable complexes with DNA, and create 
lipoplexes. These interact with the cell membrane resulting in DNA uptake by endocytosis 
[60].  
Transfections performed with electroporations were performed with the Amaxa™ 
Nucleofector™ technology using the Amaxa® Cell Line Nucleofector® Kit T. The principle 
behind this method is the creations of nanometer-sized pores in the cell membrane, by 
exposing cells to a brief pulse of electricity. DNA enters the cell through these pores, and is 
transported to the nucleus of the cell. This technique was first applied to animal cells by 
Neumann & Wong (1982) who successfully introduced plasmid DNA into mouse fibroblasts 
[60]. Larger numbers of cells may be required than for other transfection methods because in 
many cases, the most efficient electroporation occurs when there is up to 50% cell death.  
 
3.10.1: Liposome transfection protocol: 
1) Cells were grown to 50-70% confluence. 
2) The X-tremeGene HP DNA transfection reagent was warmed to room temperature, 
and then vortexed gently before use. 
3) An appropriate volume of Leibowitz L-15 culture medium without added serum was 
added to an eppendorf tube, and plasmid and transfection reagent was added in the 
ratio 1:1, 1µg DNA to 1µl transfection reagent as this was found to be the most 
optimal mix ratio in this thesis. Pipetted gently to mix completely. 
4) The mixture was incubated at room temperature for 30 minutes for complex 
formation. 
5) The complexes were distributed evenly to cells in complete culture medium. 
6) The cells were incubated for 24-72 hours in 20°C before different experiments on the 
cells were carried out. 
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3.10.2: Electroporation transfection protocol: 
1) Cells were trypsinized and counted with a hemocytometer. The appropriate number of 
cells was centrifuged at 1000 rpm for 5 minutes. Always used double the amount of 
cells needed since 50% of the cells usually die.  
2) The cell pellet was resuspended in Nucleofector solution T. 100 µl per transfection.  
3) In eppendorf tubes plasmid DNA and cell suspension was mixed: 
20µl plasmid DNA (≈1µg DNA) + 100µl cell suspension 
4) The contents of the eppendorf tubes were transferred to cuvettes and run in the Amaxa 
Nucleofector machine with the T-027 settings. 
5) The contents in the cuvettes were transferred to their incubator flask or well plates, 
previously filled with culture medium, using a Pasteur pipette.  
6) Cells were incubated for 24-72 hours at 20°C. The medium was changed after 24 
hours to remove dead cells.    
   
3.11: Infection trials 
CHSE- and ASK-cells were infected for different experiments with IPNV and ISAV 
following different setups. All infection trials were performed using adding virus at an MOI 
of 1.  
Infection of ASK-cells in 24-well plates: 
  1 3 5 7 9 
Control/Mock 
infected 
A             
B             
C             
D             
  
Cells were split with 30 000 cells in each well in 1 ml culture medium and incubated for 24 
hours at 20°C. Every other day, cells were infected with 100µl virus inoculation ≈MOI of 1, 
and pictures were taken of the cells for a time series to observe how the infection proceeded 
over time, and how infection with IPNV or ISAV differed from each other.    
← ISAV 
 
 
←IPNV 
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3.12: Fluorescence microscopy 
3.12.1: Studying the subcellular localization of RIG-I-GFP and MAVS-GFP 
 
CHSE-cells were amaxa-transfected with RIG-GFP plasmids and MAVS-GFP plasmids 
before splitting them to 8-chamber plates with 30 000 cells per chamber in 500µl culture 
medium. The cells were allowed to incubate for 24 hours at 20°C before staining with DAPI, 
Mitotracker Red CMXROs, Lysotracker Red DND-99 and Alexa Fluor® 568 Phalloidin. 
Molecular probes DAPI 
Mitotracker 
Red + DAPI 
Lysotracker 
Red 
568 phalloidin 
+ DAPI 
 
MAVS-GFP MAVS-GFP MAVS-GFP MAVS-GFP 
 
RIG-GFP RIG-GFP RIG-GFP RIG-GFP 
 
Staining with DAPI: 
DAPI is a popular nuclear counterstain for use in multicolor fluorescent techniques. Its blue 
fluorescence stands out in vivid contrast to green, yellow, or red fluorescent probes of other 
structures. DAPI preferentially stains dsDNA.  
The culture medium was carefully removed from the chamber. The cells were then washed 
twice with 500µl room temperature PBS prior to fixating cells with freshly prepared 3.7% 
PFA for 10 minutes at room temperature. Cells were then washed again twice with 500µl 
PBS. 300µl 300nM DAPI in PBS was then added to each chamber and left to incubate with 
the cells for 5 minutes before washing with PBS. A little PBS was added to the chamber 
before microscopy to keep the cells from drying. 
Staining with MitoTracker® Red: 
The MitoTracker® probes passively diffuse across the plasma membrane and accumulate in 
active mitochondria. Once their mitochondria are labeled, the cells can be treated with an 
aldehyde-based fixative for samples that need fixation to allow further processing of the 
sample. 
The culture medium was carefully removed. Mitotracker Red diluted in Leibowitz L-15 
medium without serum to 500nM was added to the chambers ≈400µl per chamber. The cells 
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were left for 30 minutes before the liquid was removed. The cells were washed twice with 
500µl PBS, before the cells were fixated for 15 minutes with 3.7% PFA.  
Staining with Lysotracker Red DND-99: 
Weakly basic amines selectively accumulate in cellular compartments with low internal pH 
and can be used to investigate the biosynthesis and pathogenesis of lysosomes. The 
LysoTracker® probes are fluorescent acidotropic probes for labeling and tracking acidic 
organelles in live cells. These probes have several important features, including high 
selectivity for acidic organelles and effective labeling of live cells at nanomolar 
concentrations. The LysoTracker® probes, which consist of a fluorophore linked to a weak 
base that is only partially protonated at neutral pH, are freely permeant to cell membranes and 
typically concentrate in acid organelles. Their mechanism of retention has not been firmly 
established but is likely to involve protonation and retention in the membranes of the 
organelles with acidic pH.  
The dye was diluted to a working solution of 75nM in PBS. 500µl was added to each chamber 
and left to incubate with the cells for at least 30 minutes in room temperature. Then the liquid 
was removed before adding 100 µl PBS to keep the cells from drying out during microscopy. 
Staining with Alexa Fluor® 568 phalloidin: 
Phallotoxins were originally isolated from the deadly Amanita phalloides mushroom and are 
bicyclic peptides. The phalloidin used in this thesis, is a derivative of this toxin but differs 
with two amino acid residues. Fluorescent phallotoxins stain F-actin at nanomolar 
concentrations and are extremely water soluble, thus providing convenient probes for labeling 
F-actin in cells.  
The cells were washed twice with 500µl PBS. Cells were then fixated with 3.7% PFA for 10 
minutes. Cells were then washed again two-three times with PBS. Then 0.1% triton X-100 in 
PBS was added to the chamber and left to incubate with the cells for 3-5 minutes. After the 
extraction the cells were then washed with PBS three times. 0.25µl Alexa Fluor® 568 
phalloidin was then added to each chamber in 200µl PBS with added BSA (0.5mg/ml). Cells 
were left to incubate with this solution for 20 minutes at room temperature. The cells were 
washed twice with PBS, before adding 100 µl PBS to keep the cells from drying out during 
microscopy.  
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3.12.2: Immunofluorescence of virusinfected cells 
 
ASK-cells were split to 8-chamber plates with approximately 30 000 cells per chamber in 
500µl culture medium. 4 plates were used: Two of the plates contained transfected cells, and 
two plates were infected with IPNV and ISAV. See setup below. Cells were amaxa-
transfected as described earlier, and cells were infected with a MOI of 1. Virus was visualized 
by using fluorescent secondary antibodies against the primary antibodies against the viruses; 
K-267 against IPNV and Falk 3H6F8 directed against ISAV HE. The latter antibody was 
kindly provided by Dr. K. Falk at The Norwegian Veterinary Institute, Oslo, Norway [63].  
0 dpi 1 dpi 3 dpi 5 dpi 
RIG-GFP RIG-GFP + IPNV RIG-GFP + IPNV RIG-GFP + IPNV 
MAVS-GFP MAVS-GFP + IPNV MAVS-GFP + IPNV MAVS-GFP + IPNV 
    0 dpi 1 dpi 3 dpi 5 dpi 
RIG-GFP RIG-GFP + ISAV RIG-GFP + ISAV RIG-GFP + ISAV 
MAVS-GFP MAVS-GFP + ISAV MAVS-GFP + ISAV MAVS-GFP + ISAV 
    0 dpi 1 dpi 3 dpi 5 dpi 
 Untreated cells IPNV IPNV IPNV 
 Untreated cells IPNV IPNV IPNV 
    0 dpi 1 dpi 3 dpi 5 dpi 
 Untreated cells ISAV ISAV ISAV 
 Untreated cells ISAV ISAV ISAV 
 
3.13: Poly I:C stimulation of cells 
Protocol: 
1) The ASK-cells were to be seeded in 24-well plates with approximately 30 000 cells 
per well in 1 ml culture medium. 
                              
                      
                                
 
2) The needed volume of cell suspension was then transferred to a 50 ml corning tube 
and diluted with the needed volume of culture medium. 
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3) 1 ml of this diluted cell suspension is then transferred to each well and the plate was 
then incubated over night at 20°C.  
4) One day after splitting the ASK-cells to 24-well plates (30 000 cells/well) the cells 
were stimulated with 10µg/ml final concentration of poly I:C in each of the 20 wells. 
The 4 wells that were left over were mock stimulated with 100µl of Leibowitz L-15 
culture medium. 
5) The 24-well plate was incubated at 20°C and samples were to be harvested at day 1, 2, 
3, 4 and 5 days post stimulation. 
6) When harvesting samples, the medium was removed from the well, and the cells were 
lysed in 350µl of RLT-buffer. The plate was allowed to incubate at room temperature 
with the RLT-buffer for approximately 2 minutes.  
7) The cell lysates was transferred to eppendorf tubes and stored at -20°C until RNA-
isolation. 
A 
Day 
1 
Day 
2 
Day 
3 
Day 
4 
Day 
5 
Mock 
stimulated 
B 
C 
D 
 
After RNA-isolation and subsequent cDNA-synthesis of the samples, the samples were 
then subjected to q-PCR analysis.  
3.14: Protein measurements 
Prior to performing the western blots, the samples from harvested cell lysates were measured 
for protein content with the kit from Pierce® BCA Protein Assay. This method was 
introduced in 1985 by Paul K. Smith, et al, and has since then become the most popular 
method for colorimetric quantitation of total protein. Bicinchonic Acid (BCA) Protein assay 
makes use of the reduction of Cu
2+
 to Cu
1+
 when peptides containing three or more amino 
acid residues i.e. proteins chelate with Cu
2+
 in an alkaline environment. This is termed the 
biuret reaction. The Cu
1+ 
produced in this first step, then reacts with two molecules of BCA 
producing a purple colored reaction product [64]. This BCA/Copper Complex exhibits a 
strong linear absorbance at 562 nm with increasing protein concentrations.  
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Figure 14: Reaction schematic for the BCA protein assay [64] 
 
Protocol: 
1) The cell lysates in RIPA-buffer with complete, was thawed on a rotator in 4°C for 30 
minutes. 
2) The reagents in the Pierce® BCA Protein Assay Kit were then mixed in this ratio: 50 
parts reagent A with 1 part reagent B. 
3) The BSA-standard (0,5mg/ml) was diluted 1:1 with RIPA-buffer. 
4) 200µ of the working solution (reagent A mixed with reagent B) was added per well in 
a 96-well plate. Sample and standard where then added in duplicates accordingly to 
the table shown below:  
Table 14: Plate setup used for BCA assays 
  1 2 3 4 …12 
A Blank 10 µl standard 5 µl sample 3     
B Blank 10 µl standard 5 µl sample 3     
C 1 µl standard 20 µl standard 5 µl sample 4     
D 1 µl standard 20 µl standard 5 µl sample 4     
E 2,5 µl standard 5 µl sample 1 5 µl sample 5     
F 2,5 µl standard 5 µl sample 1 5 µl sample 5     
G 5 µl standard 5 µl sample 2       
H 5 µl standard 5 µl sample 2       
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5) The 96-well plate was covered with plastic film/foil and then incubated at 37°C for 30 
minutes. 
6) The plate was then read in a HTS 7000 Plus Bio Assay Reader, and the absorbance 
was measured at 570 nm. 
7) The protein content was calculated by using the standard curve (OD for µg/well) and 
interpolating the protein content in each sample by the µl added. This was 
automatically done with the HTSoft 2.0 software.   
3.15: Western blots 
The term “western” blotting (Burnette 1981), refers to a procedure which involves the transfer 
of electrophoresed protein bands from a polyacrylamide gel on to a membrane of 
nitrocellulose or nylon, to which they bind strongly. Western blotting is a powerful and 
commonly used tool to identify and quantify a specific protein in a complex mixture. The 
bound proteins are then available for analysis by a variety of specific protein-ligand 
interactions, like in this case where antibodies are used to detect specific antigens [60]. 
Primary antibodies from rabbits and mice were used to probe the target, and are themselves 
detected in a sandwich reaction using a secondary antibody raised in goat and donkey directed 
towards the primary antibody. The sandwich method may also give a substantial increase in 
sensitivity, owing to the multivalent binding of antibody molecules [60].   
3.15.1: Sample preparation 
CHSE-cells were split to two 6-well plates with approximately 150 000 cells in 3 ml culture 
medium per well (see Table 6). The cells were incubated overnight in 20°C prior to infection. 
The following day the cells were infected with a MOI of 1 -> 150µl of virus inoculate per 
well (one plate with ISAV, the other with IPNV), except for the control wells that was left 
uninfected. After adding the virus, the plates were incubated over night at 13°C. Samples 
were harvested every other day with 300µl RIPA-buffer with complete, by removing the 
medium, adding the RIPA-buffer and allowing the buffer to work for 30 minutes in 4°C with 
“shaking” every five minutes. Then a cell scraper was utilized to detach the cells before the 
cell lysate was transferred to eppendorf tubes and stored at -20°C till further use. 
Table 15:The plate setup for westernblott samples 
Control, uninfected 1 dpi 3 dpi 
5 dpi 7 dpi 9 dpi 
 - 60 - 
 
3.15.2: Electrophoresis 
When an electric field is applied to a solution containing protein molecules, the molecules 
will migrate in a direction and at a speed that reflects its size and net charge. This forms the 
basis of the technique called electrophoresis. Individual polypeptide chains form a complex 
with negatively charged molecules of sodium dodecyl sulfate (SDS) and therefore migrate as 
a negatively charged SDS-protein complex through the polyacrylamide gel. Before applying 
the samples to the wells of the gel, the samples are mixed with Laemmli sample buffer that 
amongst others contains the reducing agent β-mercaptoethanol to break any –S-S- linkages in 
or between proteins. Under these conditions, proteins migrate at a rate that reflects their 
molecular weight. 
 
Figure 15: Gel electrophoresis [45] 
 The electrophoresis was performed either with precast graded 4-20% Precise™ protein gels 
from Thermo Scientific and run with a tris-HEPES-SDS buffer, or 10% polyacrylamide gels 
cast before run with Elfo-buffer. The gel was made 1.5 mm thick with 10 wells using the Bio-
Rad Mini PROTEAN casting chamber: 
1) A glass front and back plate was rinsed with ethanol before being assembled in the 
Mini-PROTEAN casting chamber.  
2) The upper and lower gel buffer was prepared. See Table 16 below. 
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3) The lower gel was mixed in a 50 ml corning tube. See Table 17. TEMED was added 
just before use, since this is the component that makes the gel set. Then the solution 
was poured into the gap between the glass plates. 
4) Isopropanol was added to the gap to make the lower gel set with a straight surface. 
The gel was allowed to set for 15 minutes. 
5) The isopropanol was gently poured off, and the components of the stacking gel was 
mixed together and poured into the gap. The plastic “comb” was then placed into the 
stacking gel to make the wells, and the gel set in 15 minutes. 
6) When the gel had set, the plastic “comb” was gently removed, and the gels were 
assembled into a container with the frontside in. The container was then filled with 
ELFO-buffer (Table 18)  
7) The samples were thawed, and mixed with Laemmli sample buffer in the ratio 1:1 
(Table 19). Then the proteins in the samples were denatured by heating the samples 
up to 95°C for 5 minutes.  
8) 20µl sample was added to each well, and the gel was run for 1-2 hours at 100V, 190 
mA.  
Table 16: Buffer solutions used for gel casting  
Solutions Reagents Amount 
Lower gel buffer Tris-base 18,17 g 
  SDS 20 % 2 ml 
  MQ ad 100 ml 
  pH was adjusted to 8.8 with NaOH/HCl 
Upper gel buffer Tris-base 6,06g 
  SDS 20 % 2 ml 
  MQ ad 100 ml 
  pH was adjusted to 6.8 with NaOH/HCl 
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Table 17: Gel solutions for western blot 
Solutions Reagents Amount 
Lower gel MQ 6,0 ml 
  Lower gel buffer 3,6 ml 
  Acrylamide 4,8 ml 
  TEMED 7,2 µl 
  APS 10 % 72 µl 
Upper gel/Stacking gel MQ 4,8 ml 
  Upper gel buffer 2,0 ml 
  Acrylamide 1,2 ml 
  TEMED 8,0 µl 
  APS 10 % 40 µl  
 
Table 18:ELFO-buffer 1 litre 
Reagent   Amount 
Distilled water   900 ml 
10X TGS Tris-Glycine-SDS-buffer 100 ml 
  Tris 25 med mer   
  Glycine 192 mM, pH 8.3   
  SDS 0,1 % w/v   
 
Table 19: Laemmli sample buffer 
Reagent Amount 
Laemmli sample buffer 2,5 ml 
MQ 2,25 ml 
β-mercaptoethanol 250 µl 
 
3.15.3: Blotting 
1) The gels were gently released from the glass plates, and put in a sandwich between 
nitrocellulose membrane, filter paper and padding in a frame. Since the proteins are 
covered in SDS with a negative charge, the proteins will move from the negative pole 
to the positive pole.  
2) The frames were placed in a container, the container was filled with blotting buffer, 
see Table 20, and a little stirring magnet and an ice block was placed into the 
chamber.  
3) The membranes were blotted for 2 hours in 4°C on a magnet stirrer at 60V, 400mA.  
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Table 20: Blotting buffer 1 litre 
Reagent Amount 
TG-buffer 100 ml 
Distilled water 700 ml 
Methanol 200 ml 
 
3.15.4: Ponceau-staining of the membrane 
The effectiveness of the protein transfer from the gel to the membrane was verified by 
staining the nitrocellulose membrane in Ponceau-solution. This solution has a bright red color 
and is water soluble making it easy to wash away after use. The protein bands on the 
membrane will be colored bright red due to the high sensitivity of the ponceau solution. 
1) The membranes are carefully removed from the “sandwich” and placed in a small 
plastic container with the protein side up. 
2) The ponceau solution was poured over, and the membranes were allowed to incubate 
in the solution until the protein bands were visible. 
3) The membranes were then cut to fitting sizes and washed in distilled water before they 
were placed in 50 ml corning tubes with the protein side inwards.   
3.15.5: Blocking 
To reduce nonspecific binding, the membrane is washed with dry milk so that the milk 
proteins can coat the nitrocellulose leaving only the target proteins the available place to bind 
for the antibodies. 
1) The membranes were washed with 5 ml TBS with 5 % dry milk 2 times for ten 
minutes on a rotator, and then for the third time for 1 hour at room temperature. 
3.15.6: Adding primary antibodies 
The traditional method for making antibodies of desired specificity is to immunize animals 
with the appropriate antigen and then prepare antisera from their blood. The specificity and 
quality of such antisera is highly dependent upon the purity of the immunizing antigen 
preparation because antibodies will be made against all the foreign components it contains.  
1) Primary antibodies were added to the tubes 1:1000, i.e. 5 µl per tube in the TBS-dry 
milk solution. 
2) The tubes were left on a rotator over night in 4°C. 
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Table 21: Primary antibodies used for westernblotts 
Virus Name of antibody Obtained from 
 
anti-actin Rabbit 
ISAV anti 6AD/9Z (HE) Rabbit 
IPNV anti-VP3 Mouse 
  
3.15.7: Adding secondary antibodies 
1) The liquid is removed, and the membranes are washed 3 times with 5 ml TBS 0.05 %, 
10 minutes each time.  
2) Adds 5 ml TBS with dry milk 5% to the tubes, and adds 1 µl secondary antibodies to 
the tubes. The tubes that had primary antibodies from rabbit, was added the secondary 
antibodies donkey anti-rabbit IgG-HRP, while the tube with the mouse-obtained 
primary antibody was added the secondary antibody goat anti-mouse IgG-HRP, from 
Santa Cruz Biotechnology.  
3) The tubes are left on the rotator in room temperature for 1-3 hours.  
4) The membranes are washed 3 times with 5 ml TBS, 10 minutes each time. 
3.15.8: Detection 
Chemiluminescent substrates are popular because they offer several advantages over other 
detection methods and yields the greatest sensitivity of any available detection method. Super 
Signal® West Femto Maximum Sensitivity Substrate Kit from Pierce Thermo Fisher 
Scientific, is an ultra-sensitive chemiluminescent substrate system for western blotting with 
horseradish peroxidase (HRP) enzyme. Chemiluminescent substrates differ from other 
substrates in that the light detected is a transient product of the reaction that is only present 
while the enzyme-substrate reaction is occurring. This is in contrast to substrates that produce 
a stable, colored product; these colored precipitates remain on the membrane after the 
enzyme-substrate reaction has terminated. 
 
Figure 16: Chemiluminescent reaction of luminol 
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1) The membranes are placed in appropriate plastic pockets.  
2) The reagents of the Super Signal® West Femto Maximum Sensitivity Substrate kit 
were mixed 1:1, reagent A with reagent B, to make the working solution. 
3) 500µl is pipetted over each membrane, and the protein bands are detected in a Chemi 
Genius
2
 Bio Imaging System from Syngene, using the software GeneSnap.   
 
3.16: TCID50 titration of virus 
This method is an end point dilution assay that quantifies the amount of virus required to 
produce CPE in 50% of the inoculated cells. CHSE-cells were used as host cells, and serial 
dilutions of either IPNV or ISAV were added. The samples was harvested from control, 
MAVS- and RIG-transfected cells, to investigate if the transfection and overexpression of 
MAVS and RIG gave any protective effects against the virus i.e. gave any reduction of 
TCID50/ml compared to non-transfected cells infected with the virus. This method is often 
used to get a picture of how much virus is needed to produce CPE in 50 % of cells, since 
knowing the actual amount of virus particles in an inoculate isn’t always indicative of how 
many virus particles that are actually able to infect a cell. In fact many virus particles are 
defective and unable of replication, and only a fraction these virus particles have been 
assembled correctly upon release from the host cell. 
Protocol used to obtain samples for later TCID50 titration:  
1) CHSE-214-cells were split, centrifuged and resuspended in Nucleofector® solution T 
as previously described. 
2) Three nunclon cell flasks (25 cm2) were filled with 5 ml Leibowitz L-15-medium as 
described in Table 6.  
3) In eppendorf tubes plasmids and cell suspension was added: 
MAVS (30,72ng/ µl) 20 µl + 100 µl cell suspension 
RIG (64,77ng/ µl) 20 µl + 100 µl cell suspension 
Control (max-GFP 0,5µg/ µl) 4 µl + 100 µl cell suspension. 
4) The contents of each eppendorf tube were transferred to 3 separate cuvettes and run in 
the Amaxa Nucleofector® on program T-027. 
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5) The contents of each cuvette were then transferred to the 25 cm2 cell flasks previously 
filled with medium by using a Pasteur pipette. 
6) The cells were then allowed to incubate for 4 days in 20°C. 
7) 4 days after the transfection, a 20 ml corning tube was filled with 1 ml of either ISAV 
or IPNV inoculate and 15 ml Leibowitz L-15 medium.  
8)  The media was removed from the cell flasks, and 5 ml of the diluted virus inoculate 
was transferred to each flask. The cells were then allowed to incubate with the virus 
for 1 hour for the virus to adhere to the cells.  
9) The virus inoculate was removed and 5 ml new Leibowitz L-15 medium was filled in 
each cell flask.  
10) The cells were then incubated at 13°C 
500µl of the media was then harvested every other day (day 1, 3, 5 and 7 post infection) and 
stored at -20°C until TCID50-titration.    
Protocol for TCID50 titration:  
1) CHSE-214-cells were washed three times with 5 ml PBS, before subsequent 
detachment with 0.05 % trypsin-EDTA.  
2) To neutralize the residual activity of the trypsin, Leibowitz L-15 medium with serum 
was added to 10 ml in total.  
3) The cells were then counted in a hemocytometer. For 96-well plates approximately 
10 000 cells should be seeded in each well, and 0,2 ml medium/well is sufficient.  
 
                             
                              
                                  
 
                                                                 
                        
4) The calculated amount of medium and cell suspension was mixed and 200 µl of this 
diluted cell suspension was pipetted over each well. 
5) The 96-well plates were incubated at 20°C over night. 
6) The harvested virus samples were thawed at room temperature one day after the cells 
were split to 96-well plates. The samples used were the samples harvested at day 3 and 
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5 for both IPNV- and ISAV-infected cells that were transfected with max-GFP, 
MAVS or RIG. 100µl of the virus sample were then diluted with 900µl of L-15 
medium 1:10, and serial diluted 1:10 six times so that we ended up with 6 dilution 
series.  
7) 100 µl of virus inoculate 1: 10 was added to wells 1 A-H, 100 µl of virus inoculate 
was added to wells 2 A-H and so on…  
8) The 96 well plates were covered with plastic cover tape sheets and incubated at 13°C 
for the appropriate days depending on which virus used. IPNV usually needed ca 7 
days, but the ISAV needed several weeks. This was the general plate setup: 
 
  1 2 3 4 5 6 7 8 9 10 11 12 
A 
1E-
0,1 
1E-
0,2 
1E-
0,3 
1E-
0,4 
1E-
0,5 
1E-
0,6 
1E-
0,1 
1E-
0,2 
1E-
0,3 
1E-
0,4 
1E-
0,5 
1E-
0,6 
B 
C 
D 
E 
F 
G 
H 
 
Day 3: control, MAVS or RIG Day 5: control, MAVS or RIG 
 
9) After the incubation, the medium was removed from the 96-well plates by decanting. 
10)  200µl of the crystal violet solution described in Table 7 was added to each well with 
a multi pipette.  
11) The plates were left to incubate for 20 min at room temperature before the staining 
solution was gently removed.  
12) The plates were then submerged in a bucket of water with the tap running to gently 
wash the plates.  
13) The plates were then allowed to air dry before the positive wells (wells where CPE 
was apparent) i.e. the wells that weren’t stained with the crystal violet was counted 
and the plates were photographed on a light box.  
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14) The TCID50 and the TCID50/ml was then calculated by using Reed and Muench 
TCID50-calculator, an infectivity calculator that can be easily found on the internet 
[65].  
In addition to this, the crystal violet dye was redissolved in 100µl of 1% SDS solution, and 
the optical density (OD) was read on the 96-well plate measuring the absorbance at 590 nm 
using the HTS 7000 Plus Bio Assay Reader. This was done to aid in reducing the subjectivity 
of determining whether a well is positive or negative by eye [41]. 
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4: Results 
4.1: Viral infection of cells with IPNV and ISAV 
 
Infection of CHSE-cells with these two pathogenic viruses produced different effects. 
Generally IPNV produced a more prominent CPE, with the cells round up and detaching after 
4-5 days (Figure 17). With ISAV the cells did not produce a prominent CPE even when the 
cells were incubated with the virus for several weeks. The cells however became vacuolarized 
although they did not detach from the surface as seen in Figure 18. 
 
Figure 17: IPNV infection in CHSE cells. 40X 
 
Control 1 dpi 
3 dpi 5 dpi 
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Figure 18: ISAV infection in CHSE-cells. 40X 
 
4.2: Viral replication of ISAV and IPNV 
 
To monitor viral replication of ISAV and IPNV in ASK-cells by means of increased mRNA 
levels of ISAV segment 7 and IPNV segment A, Q-PCR was performed on cDNA from total 
RNA samples from infected ASK-cells at 1, 3, 5, 7, and 9 days post infection. The ASK-cells 
had been infected with an MOI of 1. The figure presented below shows the relative expression 
of segment 7 in ASK-cells calculated relative to day 1 post infection. Relative expression 
levels were calculated in REST® for days 3-9 post infection. The level of mRNA for ISAV 
segment 7 increased steadily throughout the sampling period and reached a level more than 
210 times the level at day 1 post infection. This demonstrated that ASK-cells are permissive 
for this virus. 
Control 1 dpi 
3 dpi 5 dpi 
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Figure 19: Relative mRNA transcription of IPNV segment A at 1, 3, 5, 7, and 9 days post 
infection.  
As seen in Figure 1919  above, the transcription of IPNV segment A increased significantly 
until day 3 post infection relative to day 1 post infection, with a factor of 14.38, p-value: 
0.021.  However, at later sampling points, the mRNA levels for segment A was reduced to 
levels observed at day 1 post infection, probably reflecting the strong cytopathic effect of this 
virus on ASK-cells (see Figure 17). 
 
4.3: Western blotting 
 
  
Figure 20: Left panel:Western blot of IPNV VP3. Included are control, and days 1, 3, 5, and 
7 post infection.  Right panel: Western blot with the same samples with antibodies against 
actin. 
C 1 3 5 7 C 1 3 5 7 
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From the western blots seen above, the control with no virus shows no bands for VP3. From 
the western blot it is also apparent that VP3 is synthesized in the IPNV infected cells already 
from day 1 post infection indicating that this is a viral protein that is synthesized early after 
infection. The following days the bands appear weaker that could suggest that the 
transcription of this protein is reduced after the first day, but the most likely explanation is 
that as the viral infection proceeded and CPE were more extensive, the samples were 
harvested at a less efficient level than for the first days. For the western blot where antibodies 
against actin were used, the control shows a clear band, which can also be seen for day 1 post 
infection. For days 3, 5, and 7 post infection no bands can be readily observed, which may 
account for loss of harvested cells due the extensive CPE observed in the samples. When 
harvesting the samples, the media was removed. This media contained a significant amount of 
detached cytopathic cells, and was for this reason centrifuged, and the cell debris pellet was 
lysed together with the cells still attached to the wells. This was done to extract as much of 
the samples as possible, but as the western blots show, this was obviously not done efficiently 
enough.  
Despite several attempts at western blots with ISAV antibody, no successful blot could be 
produced to confirm ISAV replication at the protein level.  
 
4.4: Relative expression of target genes in Poly I:C-stimulated cells 
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Figure 21: Effect of poly I:C stimulation (10 ug/ml) on relative expression of target genes. 
Each point represents 4 measurements from 2 independent experiments and is calculated 
relative to 2 reference genes (18S and EF1α) using ΔΔCt method. 
To verify that the ASK cells were responsive to an established inducer of the interferon 
pathway we treated our cells with 10 ug/ml doublestranded polyI:C RNA and analysed 
transcription of a selection of inflammatory and interferon induced genes (ISGs).  Despite a 
rather “bumpy” appearance of the time series data, the general trend was that poly I:C 
treatment of the ASK cells induced significant overexpression of the investigated transcripts 
at most time points (Figure 21). The relative expression of IFNa was significantly up-
regulated on day 1 and day 5 after poly I:C stimulation, displaying a bimodal curve with 
peaks on these days. However on day 2 and day 3 post stimulation, the relative expression of 
IFNa decreases slightly before finally increasing again at day 4 post stimulation. Also 
displaying this bimodal curve in relative expression is the target gene Mx. Mx was 
significantly up-regulated on day 1 post stimulation (p-value: 0.033) with an expression ratio 
of 2.3, and on day 5 post stimulation with an expression ratio of 2.76 (p-value: 0.001), 
showing that IFNa and Mx expression was induced early by the poly I:C stimulation before it 
decreases and then being up-regulated at a later time point. ISG15 was induced from day 1, 
but the increase in expression was not significant until day 3 post stimulation with a relative 
expression ratio of 2.77 (p-value: 0.001).  The relative expression of GRP78 was significantly 
up-regulated at day 1 post stimulation, but then decreased to control levels . Another gene that 
was significantly up-regulated was TNFa on day 3 post stimulation with poly I:C, with an 
expression ratio of 3.37 (p-value: 0.023). The relative gene expression of IL-1β did not 
significantly change during these five days post stimulation with poly:IC.     
 
4.5: Effect of viral infection on transcription of genes involved in inflammation 
The relative expression of the six virus responsive genes presented here has been normalized 
against two reference genes; elongation factor 1 alpha, and 18S by using the ΔΔCq-method. 
The relative expression levels have been set to one for day 0 (control), as this is the base line 
level.  
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4.5.1: Relative expression of target genes in ISAV-infected cells 
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Figure 22: Effect of ISAV infection in ASK-cells on relative expression of inflammatory 
transcripts analyzed by Q-PCR. Each point represents 8 measurements from 2 independent 
experiments and is calculated relative to 2 reference genes (18S and EF1α) using ΔΔCt 
method. 
At day 1 post infection with ISAV an increase in the relative expression of the ISG15 target 
gene was observed (Figure 22). A distinctive decrease in the relative expression levels for 
GRP78, IL1β and TNFa was apparent 1 dpi (p-value: 0.020, 0.026, 0.028 respectively) but 
these levels increased significantly on day 7 post infection for all three genes (p-value: 0.003, 
0.002, 0.011 respectively). IFNa was significantly up-regulated from day 3 post infection (p-
value 0,001) and steadily increased until a peak was reached at day 7 post infection with a 
relative expression ratio of approximately 284,5 (p-value 0,007). ISG15 was the only target 
gene that was significantly up-regulated at day 1 post infection with an expression ratio of 
15.1 (p-value: 0.001). Its expression further increased on day 3, and reached a peak on dpi 7, 
with an expression ratio of 51.8 (p-value: 0.001). Its expression was significantly up-regulated 
throughout the nine days post infection. ISG15 apparently follows a similar expression pattern 
to IFNa, but is induced earlier than IFNa by the ISAV-infection, which may suggest that there 
exists alternative mechanisms of inducing ISG15 than IFNa-induction alone. The TNFa gene 
was down-regulated on day 1 post infection (expression ratio: 0.078, p-value: 0.014), but not 
significantly different from control later in infection. The pro-inflammatory cytokine IL-1β 
was significantly down-regulated on day 1 post infection with an expression ratio of 0.27 (p-
value: 0.026), significantly up-regulated on dpi 3 with the expression ratio 1.52 (p-value: 
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0.001) and unchanged at 5 dpi, before a significant increase on dpi 7 and 9. IL-1β showed the 
highest up-regulation on day 9 post infection with an expression ratio of 6.57 (p-value: 0.001) 
showing that an inflammatory reaction in the ASK-cells is in fact induced in these ISAV-
infected cells.         
4.5.2: Relative expression of target genes in IPNV-infected cells 
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Figure 23: Effect of IPNV infection in ASK-cells on relative expression of inflammatory 
transcripts analyzed by Q-PCR. Each point represents 8 measurements from 2 independent 
experiments and is calculated relative to 2 reference genes (18S and EF1α) using ΔΔCt 
method. 
As with the ISAV-infected ASK-cells, a strong down-regulation of the pro-inflammatory 
TNFa-gene was observed with an expression ratio of 0.092 (p-value: 0.001) on day 1 post 
infection with IPNV (Figure 23). There was also a significant down-regulation of the 
expression of the chaperone protein GRP78 on day 1 post infection (expression ratio: 0.293, 
p-value: 0.001). A relatively strong up-regulation of the ISG15 gene throughout the infection 
was observed with IPN-virus. ISG15 was significantly up-regulated from day 1 post infection 
with an expression ratio of 43.8 (p-value: 0.130), reaching an expression ratio of 60.3 (p-
value: 0.012) on day 5 post infection. It remained nearly unchanged until day 9. Interestingly 
the relative expression of the IFNa gene was not as strongly up-regulated by IPNV-infection 
as observed with ISAV-infection. The IFNa gene was significantly up-regulated from day 3 
post infection with an expression ratio of 4.43 (p-value: 0.028), reaching the highest 
expression ratio of 10.66 (p-value: 0.017) on day 5 post infection. The relative expression of 
the antiviral Mx protein increased steadily from day 1 post infection, and reached a peak at 
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day 7 with an expression ratio of 4.54 (p-value: 0.001). It was also observed that the 
chaperone protein GRP78 was significantly up-regulated from day 5, reaching a peak on day 
7 post infection with an expression ratio of 3.33 (p-value: 0.001) before decreasing again at 
day 9.  
4.6: Effect of transfection on transcription of genes involved in inflammation      
4.6.1: Relative expression of target genes in RIG-I-transfected cells 
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Figure 24: Effect of RIG-I transfection in ASK-cells on relative expression of inflammatory 
transcripts analyzed by Q-PCR. Each point represents 8 measurements from 2 independent 
experiments and is calculated relative to 2 reference genes (18S and EF1α) using ΔΔCt 
method. 
On day 1 post transfection with the RIG-I plasmids (using the electroporation transfection 
method) a significant increase in the relative expression of IFNa was observed with IFNa 
reaching an expression ratio of 6.72 (p-value: 0.007) (Figure 24). At later time points, the 
IFNa expression was not different from control. The expression of the Mx-gene was 
significantly up-regulated between 4,27 fold and 4,90 fold all sampling points after RIG-I 
transfection. The Mx expression pattern followed that of the IFNa expression, but its up-
regulation was sustained during the sampling period. Interestingly the ISG15 gene expression 
was not induced despite of the IFNa being up-regulated day 1 post transfection.  
The chaperone protein GRP78 was significantly up-regulated following transfection with the 
RIG-I-plasmid from day 1 till day 9.  
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The pro-inflammatory cytokine IL-1β was significantly up-regulated day 1 post transfection 
(expression ratio: 6.04, p-value: 0.001) before a strong and significant down-regulation was 
observed at days 3, 5 and 7 post infection. The up-regulation observed at day 1 post 
transfection is not unexpected, as the electroporation method in itself is expected to induce a 
transient inflammation. The pro-inflammatory cytokine TNFa is also significantly down-
regulated on day 5 (expression ratio: 0.26, p-value: 0.013) and day 7 (expression ratio: 0.31, 
p-value: 0.011) post transfection.         
4.6.2: Relative expression of target genes in MAVS-transfected cells 
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Figure 25: Effect of MAVS-transfection in ASK-cells on relative expression of inflammatory 
transcripts analyzed by Q-PCR. Each point represents 8 measurements from 2 independent 
experiments and is calculated relative to 2 reference genes (18S and EF1α) using ΔΔCt 
method. 
On day 1 post transfection a strong up-regulation of IFNa was observed with an expression 
ratio of 36.53 (p-value: 0.001) (Figure 25). After 1 day post transfection the relative 
expression levels of this gene decreased rapidly to a ratio of 5.11 (p-value: 0.001) at day 3 
post transfection and then further decreases.  
The antiviral Mx gene was significantly up-regulated from day 3 post transfection. The ISG15 
gene did not significantly change during the 9 days after transfection, but its expression  seem 
to correlate with that of the IFNa gene.  
GRP78 was significantly up-regulated by MAVS overexpression during the sampling period.  
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The pro-inflammatory cytokine IL-1β was significantly up-regulated on day 1 post 
transfection, with an expression ratio of 21.23 (p-value: 0.001). However the expression ratio 
fell to control values at later time points. 
 
4.7: Comparison of the different target gene expressions as a result of infection and 
transfection: 
 
 To better visualize the effect of the different treatment on interferon related transcripts figure 
26 shows the same data (Figure 22-25) as above for IFNa in aggregated plot. 
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Figure 26: Comparison of the relative IFNa gene expression following different treatments 
(data from figure 22-25). 
  When the temporal pattern of IFNa expression after infection or RIG-I/MAVS 
overexpression was compared it can be seen that overexpression resulted in a more rapid, but 
transient IFNa induction compared to viral infection (Figure 26)). At day 1 post treatment the 
highest induction of the IFNa gene can be seen with the MAVS-transfection, with the RIG-
transfection on second place. The ISAV-infection did not significantly induce the IFNa gene 
on day 1 post infection. Relatively low expression ratios of IFNa can be observed with the 
IPNV-infection compared to the ISAV-infection. ISAV-infection clearly induced a strong 
IFNa up-regulation compared to both transfections and the IPNV-infection. The lowest IFNa 
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induction can be associated with RIG-I-transfection, and even a slight down-regulation can be 
observed at day 5 post transfection.  
The same was true for the kinetics of MX expression, but this transcript was sustained at an 
elevated level after all treatments (Figure 27). However, the other interferon regulated 
transcript, ISG15, was mainly stimulated by viral infection and not by RIG-I overexpression 
(Figure 288). The chaperone GRP78 was much more stimulated by protein overexpression 
than by viral infection throughout the observation period (Figure 29). Transcription kinetics 
for the cytokines IL-1β and TNFa was also preferentially induced by MAVS/RIG-I 
overexpression with a strong burst at day 1 followed by levels at, or below control at the later 
stages (not shown). 
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Figure 27: Comparison of the Mx gene expression following different treatments (data from 
figure 22-25). 
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Figure 28: Comparison of the ISG15 gene expression following different treatments (data 
from figure 22-25). 
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Figure 29: Comparison of the GRP78 gene expression following different treatments (data 
from figure 22-25). 
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 4.8: Transfection of cells 
Although the intended purpose of plasmid transfection with RIG-I and MAVS genes was to 
increase their protein expression levels in the cells, the transfection procedure and the 
introduction of plasmid DNA into cytoplasm may have other effects on the cells. Several 
times during the work with this thesis, it was observed that transfection with the full-length 
RIG-I plasmid caused significant cell death compared to transfections done with the MAVS-
plasmid although both these inserts were in the same expression vector (pcDNA1.1/Amp) 
(Figure 30). The transfections were done with the same plasmid concentrations under the 
same conditions using the same amount of cells, and this was a consistent observation. The 
electroporation as a transfection method is associated with a significant loss of cells, but 
fewer viable cells were observed when transfecting with pcDNA1.1/Amp with the RIG-I-
insert. One possible explanation could be the size of the insert in this pcDNA1.1/Amp-vector 
as the MAVS-insert is almost 2 kb, whereas the RIG-I-insert is nearly 4 kb long.   
  
Figure 30: Left: ASK-cells transfected with pcDNA1.1/Amp-RIG-I. Right: ASK-cells 
transfected with pcDNA1.1/Amp-MAVS. 10X magnification. 24 hours post transfection with 
1µg of plasmid-DNA 
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4.8: Fluorescence microscopy 
4.8.1: The subcellular localization of RIG-I-GFP and MAVS-GFP 
CHSE-214 cells were transfected with plasmids containing RIG-I-GFP and MAVS-GFP 
inserts to study the distribution and subcellular localization of these proteins in the cell.  
  
Figure 31: Fluorescence micrographs of CHSE cells expressing MAVS-GFP. Right panel: 
MAVS-GFP (green color) together with MitoTracker Red (red color) and DAPI (blue color) . 
Left: MAVS-GFP and MitoTracker Red overlay showing colocalization (yellow). 
In cells transfected with MAVS-GFP the green label appeared to co-localize with the 
MitoTracker in many of the transfected cells (as MAVS is a mitochondrial membrane protein) 
like in Figure 31, left panel.  The co-localization of GFP and MitoTracker red produced a 
yellow color when studying the mounts in the fluorescence microscope. However, it was 
frequently observed that when overexpressing MAVS-GFP, this protein could be observed as 
blebs near the nucleus of the cell, as seen in the left panel of figure 32. This was often 
observed from 2 days post transfection with MAVS-GFP. This could indicate that when the 
cells were overexpressing MAVS, the transport system where newly synthesized proteins are 
transported out from the ER is saturated and this protein is not evenly distributed as it would 
be at normal expression levels. There was no co-localization of MAVS-GFP with the 
lysosomal marker (figure 32, right panel). 
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Figure 32: Right: Fluorescence micrographs of CHSE cells expressing MAVS-GFP. Right 
panel: MAVS-GFP (green), DAPI (blue) and LysoTracker (red) Middle panel: MAVS-GFP 
(green) and DAPI (blue) Left panel: MAVS-GFP (green), phalloidin (red), DAPI (blue) 
 
 
Figure 33: Fluorescence micrographs of CHSE cells expressing RIG-I-GFP. Right panel: 
Phase contrast of RIG-GFP transfected CHSE cells. Left panel : RIG-I (green),  DAPI (blue) 
and Cellmask (red). 
When transfecting with RIG-I-GFP, this protein showed an even distribution throughout the 
cytosol of the cell (figure 33 right panel). However more often than not, the RIG-I-GFP a 
couple of days after transfection, could be observed as vacuoles in close proximity to the cell 
nucleus. Sometimes RIG-I-GFP even showed a co-localization with the nucleus (figure 33 left 
panel). Overexpressing RIG-I may alter the natural distribution of this protein in these cells. 
Whether this is attributed to the fact that the proteins are overexpressed or that the GFP-tag 
attached to the RIG-I and MAVS may alter the function and distribution of them, remains 
unclear. One should also keep in mind that the RIG-I-GFP is not the full-length RIG-I but the 
N-terminal end fused with the GFP and that this may also contribute to a possible alteration of 
subcellular distribution.    
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4.8.2: Effects of transfection on IPNV and ISAV infection 
 
CHSE-cells were transfected with RIG-I-GFP and MAVS-GFP and subsequently infected 
with IPNV and ISAV (MOI of 1) to investigate if the transfection could have any positive 
effects in offering the cells any protection against infection with these two pathogenic viruses. 
First, the degree of infection was analysed by quantitation of immunopositive cells in the 
microscope at 24 h after inoculation. The infection degree was by staining the nuclei of cells 
with DAPI to count the total amount of cells, compared to infected cells (stained with 
fluorescent antibodies against the viruses).  
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Figure 34: Percent infected cells (immuno fluorescence positive cells) at 24 h p.i. in CHSE 
control cells and in cells overexpressing MAVS or RIG-I. Bars show mean % 
immunopositive cells ± SD (n= between 200 and 600 in each group) (star denotes value 
significantly different from control p<0.05) 
  
Although it may seem like RIG-transfection conferred some protection against ISAV 
infection, this turned out to be difficult to determine as for all the transfected samples. The 
same quantitations were performed for later time points p.i., but the infected cells were 
washed out by the washing steps involved in immuno-staining. The reason for this was 
probably that the cells did no longer adhere strongly to the chamber after 3-5 days of 
infection, and transfection seemed to aggravate this effect. The loss of cells during staining 
procedures was too big to give any conclusive results for day 3 and 5, so only the results for 
day day 1 is commented and represented in Figure 34. Coating of the chambers with poly-L-
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lysine was performed prior to splitting the cells into the chambers, and in addition to this the 
washing steps were shortened in an attempt to reduce the number of cells lost. This 
unfortunately did not reduce the number of cells lost due to staining procedures. In addition to 
this, the transfection degree obtained was often low, even after transfection with the 
electroporation method. One must assume that transfecting only a few cells will not protect 
the entire cell population. It was also observed that cells that were transfected (GFP positive) 
did get infected with both IPNV and ISAV.   
Counting results were analyzed in SigmaPlot with ANOVA (analysis of variance). The 
differences in the median values among the treatment groups for ISAV samples were not 
great enough to exclude the possibility that the difference was due to random sampling 
variability; there was not a statistically significant difference between the groups (P = 0,514) 
i.e. the interpretation of this result was complicated by the ISAV samples not following a 
normal distribution.  
However, the differences in the mean values among the treatment groups for IPNV samples 
were greater than would be expected by chance; and there was a statistically significant 
difference (P = 0,025) for control versus RIG-I as seen in Figure 34. There was no significant 
difference for control versus MAVS, and MAVS versus RIG-I.    
  
4.9: TCID50 titration 
 
To analyse the effect of transfections on the secretion of virus to the cell culture supernatant 
(= virus production) the TCID50 for the supernatant from the transfected and non-transfected 
cells infected with IPNV were determined. On day 3, medium from nontransfected cells 
infected with IPNV had a TCID50/ml of 4.49x10
2
. After 5 days the levels of virus was in the 
same range (TCID50/ml = 3.29x10
2
). For the MAVS transfected cells  + IPNV on day 3 and 5 
no TCID50 could be determined as not enough wells were positive i.e. CPE had not appeared 
in sufficient number of wells. This also applies to the ISAV titrations were all wells were 
negative even after 5 weeks with incubation also for the non-transfected control samples. 
Below the titration-plates for IPNV are presented. The titration-plates for ISAV are not 
presented as they are all negative and could not be used. 
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Figure 35: The 96-well plate used for TCID50 titration of the control samples infected with 
IPNV. 
 
Figure 36: The 96-well plate used for TCID50 titration of MAVS transfected cells infected 
with IPNV. 
   
As an alternative to the failed TCID50 calculation, the relative number of intact cells was 
determined by spectrophotometric analysis of the cellular stain.  After the plates were 
photographed under a light box, the crystal violet dye was redissolved in 100 µl 1% SDS 
solution and the optical density (OD) was read at 590 nm with the HTS 7000 Plus, Bio Assay 
Reader from Perkin Elmer. The optical densities at 590 nm were plotted in excel® and the 
MAVS + IPNV (Day 3) MAVS + IPNV (Day 5) 
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means and standard deviations of 8 wells per virus dilution ,  (SD) and standard error (SE) 
were calculated before the graphs were made. In the graphs below, the data shown are average 
optical densities ± SE against the log10 dilutions.  
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Figure 37: Average optical densities ± SE for the viral titration plates. 
 
As the graphs above show, the average optical densities increase with increasing dilution 
factor. This could be expected as more dilute virus supernatants should produce a less 
prominent CPE than less dilute virus supernatant and leave more viable cells available for the 
crystal violet staining. Although no TCID50 could be determined for the samples with MAVS 
transfected cells infected with IPNV, transfected cells have a generally higher OD (more 
viable cells?) than the control samples infected with the same virus MOI. However 
unfortunate it is that the TCID50 could not be determined for the MAVS samples, this viral 
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titration experiment may suggest that MAVS-transfection and overexpression in the cells may 
confer some level of protection against IPNV. But further investigations are needed to 
confirm this hypothesis. 
As mentioned earlier, no TCID50 could be determined for ISAV4. Although the CHSE-cells 
has in previous studies been confirmed to be permissive for ISAV [50], and this particular 
ISAV strain has been demonstrated to be associated with relatively high mortality [10], it did 
not produce a significant CPE in the TCID50 titration, even after 7 and 8 weeks. This could be 
due to the number of passages the CHSE-cells had, as it has been shown that after the cells 
has been split many times, they become refractory to infection with ISAV. However changing 
to a new CHSE-cells with a lower passage number, did not solve the problem. The number of 
times the virus has been passaged is also of great importance. Every time the virus replicates, 
non-infective or defective virions are assembled, and after a sufficient number of passages, 
the virus inoculate may no longer be as infective or pathogenic as the first isolate. This could 
be a possible explanation to why no prominent CPE was observed with this virus during the 
work with this thesis.    
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5: Discussion 
The innate immune system is the first line of defense against infectious pathogens and is 
especially critical for the teleost fish as the adaptive immune response is not as specific as the 
mammalian system. Surveillance mechanisms involve pattern recognition receptors (PRRs) 
on the cell surface and in the cytoplasm. Three families of PRRs have been identified to date; 
the TLRs, the NLRs and the RLRs. The RLR signaling pathway induces an antiviral immune 
response upon recognition of viruses, including the production of pro-inflammatory cytokines 
and type I IFNs.   
In this thesis salmon cell lines were infected with ISAV and IPNV to study the intracellular 
biochemical changes that is initiated during an infection with these aquatic pathogenic 
viruses. The importance of RIG-I and MAVS on virus replication and the development of 
CPE in the cell lines were investigated by transfecting cells with plasmids containing these 
inserts. The GFP-variants of these proteins were used to transfect cells to examine the 
subcellular localization of these proteins in the cell lines ASK and CHSE-214.  
 
5.1: ASK- and CHSE-cells 
 
Both ASK- and CHSE-cells were shown to be permissive cell lines for the IPN- and ISA-
virus replication for the strains that were used, producing an effect in infected cells as seen in 
Figure 17 and Figure 18. The western blot of IPNV also verifies that IPNV does replicate in 
CHSE-cells (Figure 20) which has been confirmed previously in several studies [66, 67]. The 
Q-PCR results of ISAV segment 7 and IPNV segment A (Figure 19), also confirms that there 
indeed is a replication of these viruses in ASK-cells. ISAV has previously been confirmed to 
replicate in CHSE-cells [9, 17, 68] and ASK-cells [30] which was also confirmed during the 
work with this thesis.  
Furthermore it was investigated whether the ASK-cells were responsive to an established 
inducer of the interferon pathway, by treating our cells with 10 ug/ml double stranded poly 
I:C RNA and analyzing transcription of a selection of inflammatory and interferon induced 
genes (ISGs). This was included as a positive control to confirm that the ASK-cells contained 
all the components of the signaling pathway needed (see Figure 21).         
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5.2: ISAV infection 
 
The ISAV4 strain used in this thesis did not produce any prominent CPE in ASK-cells or 
CHSE-cells that were used, although this ISAV strain has been demonstrated to be associated 
with high mortality in salmon [10]. This could be due to high passage number of the cell lines 
used, as this could cause the cells to be refractory to ISAV infection, but this is probably not 
the explanation as changing the cells to a new batch with lower passage number did not aid in 
any way. A more probable explanation is that the virus may have been attenuated when it was 
propagated in ASK-cells, as every replication cycle for the virus, carries with it the risk of 
defective and non-infective virions to be produced and assembled. The virus supernatant used 
in the infection trials in this thesis, were from a virus supernatant propagated in ASK-cells 
where they produced a cytopathic effect after 10 days. However this new virus supernatant 
harvested from this virus propagation did not produce any further CPE when inoculated in 
new infection experiments. Although neither the ASK- or the CHSE-cells died when 
inoculated with ISAV4 during this work, the cells did however change their appearance, 
which could be readily observed in a phase contrast microscope. The cells did not detach or 
round up, but the ISAV4-infection did induce the cells to become vacuolarized, and induced a 
granular appearance (especially pronounced at day 5 post infection) as shown in Figure 18.  
Our in vitro studies showed that ISAV is an early and powerful inducer of interferon and 
interferon induced genes Mx and ISG15. This is consistent with the findings of Kileng et al. 
and Jensen et al.[69, 70] in earlier studies. ISAV-infection induced a significant IFNa up-
regulation in ASK-cells. IFNa was significantly up-regulated from day 3 post infection (p-
value 0,001) and steadily increased reaching a peak at day 7 post infection with a relative 
expression ratio of approximately 284,5 (p-value 0,007). Although the IFNa gene was up-
regulated by the ISAV infection as seen in Figure 22, it has been suggested in previous 
studies that even though this gene is up-regulated by the infection with this virus, it does not 
protect against the ISAV infection [30], in fact interferon-signaling antagonist viral proteins 
have been described [71, 72]. These proteins could be used by the virus as a strategy to evade 
the IFN system as has been described for mammalian viruses [73]. These results appear to 
indicate that induction of type I IFN and IFN dependent genes in ISAV infected cells may not 
provide protection against the virus. 
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IL-1β was significantly up-regulated at 7 and 9 dpi in ASK-cells. This has also been observed 
in a previous study performed in vivo in ISAV infected fish [74]. This may suggest that IL-1β 
can have a role during ISAV infection as it has been described for other orthomyxoviruses 
like Influenza A [75].          
ISAV infection significantly up-regulated the transcription of ISG15 as seen in Figure 22. A 
study by Røkenes et al. [76] demonstrated the immunoprecipitation of ISAV protein from 
infected TO cells using anti-Atlantic salmon ISG15 anti-serum, which suggested that binding 
between the ISG15 and the ISAV nucleoprotein occurred. This suggests the possible antiviral 
role of Atlantic salmon ISG15 in ISAV infection of Atlantic salmon. 
5.3: IPNV infection        
 
IPNV readily produced a pronounced CPE in both ASK- and CHSE-cells when infecting the 
cells with a virus MOI of 1. All infection trials performed in this thesis were done with an 
MOI of 1. Although both the ISAV and IPNV were inoculated in cells with the same MOI, 
IPNV gave a more pronounced pathogenic effect on the cells compared to ISAV. Total CPE 
with IPNV was usually achieved after 3-4 days post infection, and the cells were clearly 
detached from the surface being more refractile (brighter) under phase contrast microscopy as 
seen in Figure 17. Interestingly CHSE-cells infected with IPNV showed a morphological 
change before the CPE was evident, in form of disruption of the cell membrane. This has also 
been observed in a previous study [67], where the authors suggested that the disruption 
observed of the cell membrane may be attributed to apoptosis of the cells. Host cell apoptosis 
is part of the innate immune response to virus infection, serving to limit the progeny 
production of the virus [67].  
A significant up-regulation of GRP78 was observed during IPNV infection of ASK-cells. 
This may suggest that the lumen of the endoplasmatic reticulum of the cell experiences an 
increase in newly synthesized proteins (perhaps viral proteins) being translocated to the ER, 
or it may be an up-regulation of GRP78 induced to protect the cell against apoptosis 
(programmed cell death). This might be an intended effect of the IPN-virus, as apoptosis 
induced at the wrong time point may interfere with the virus replication. The relative 
expression of the pro-inflammatory cytokines IL-1β and TNFa remains relatively unchanged 
during all sampling points, suggesting that IPNV does not induce an inflammatory reaction in 
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ASK-cells. This is also consistent with the findings of another study, where IPNV infection in 
Atlantic salmon smolts failed to induce IL-1β and TNFa [30, 74].  
Interestingly the relative expression of the IFNa gene was not as strongly up-regulated by 
IPNV-infection as observed with ISAV-infection. The IFNa gene was significantly up-
regulated from day 3 post infection with an expression ratio of 4.43 (p-value: 0.028), and 
reached its highest expression ratio of 10.66 (p-value: 0.017) on day 5 post infection. It is 
clear that IPNV has evolved mechanisms to overcome the IFN responses. Viral proteins VP4 
and VP5 seem the most probable candidates responsible for interfering with the IFN-signaling 
pathway in salmon [77]. Concerning interferon signaling, as McBeath et al.[74] indicated, the 
induction of the IFN system by IPNV seems to involve complex virus/host interactions and 
may play a role in determining states of resistance/susceptibility. Moreover, IFN signaling 
after IPNV infection may be dependent on the type of cell infected. However, IPNV may not 
have developed mechanisms to counteract IFN induced antiviral proteins because cells treated 
with Atlantic salmon IFN are effectively protected against IPNV induced lysis as 
demonstrated by Robertsen et al. [78].  
ISG15 was significantly up-regulated during IPNV infection at all sampling points. This has 
also been observed in a previous study for both IPNV and ISAV [76]. Although ISG15 
homologues have been identified in several fish species like crucian carp, goldfish, Atlantic 
salmon and Atlantic cod, little information exists about their biological properties [42, 76].      
5.4: MAVS transfection 
 
MAVS transfection in CHSE-cells appears to confer some protection against IPNV as 
demonstrated by higher OD-values from the TCID50 titration but interpretation of these results 
were difficult due to few positive wells. However this effect was not observed when CHSE-
cells were transfected with MAVS prior to immunostaining as presented in Figure 34 as the 
MAVS sample values did not significantly differ from the control values.  
The target gene GRP78 was significantly up-regulated at all sampling points in MAVS 
transfected ASK-cells (Figure 29). This was not unexpected, and suggests an induction of 
protein synthesis, which one could expect after a transfection with a plasmid that is 
transcribed inside the cell. The transfection itself influences the relative expression of target 
genes.  
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MAVS co-localized with the mitochondrial marker as shown in 31, confirming that it shares 
this essential location with its mammalian counterpart. This has also been demonstrated in 
several studies on MAVS [34, 37, 38]. However, it was frequently observed that when 
overexpressing MAVS-GFP, this protein could be observed as blebs near the nucleus of the 
cell, as seen in Figure 32. This was often observed from 2 days post transfection with MAVS-
GFP. This could indicate that when the cells were overexpressing MAVS, the transport 
system where newly synthesized proteins are transported out from the ER is saturated and this 
protein is not evenly distributed as it would be at normal expression levels. Another 
explanation is that overexpression of MAVS-GFP by transfection, induces a stress response in 
CHSE-cells and forms large aggregates as discussed by Hou et al. [37].  
5.5: RIG-I transfection 
 
When overexpressing RIG-I in ASK-cells, the chaperone GRP78 was significantly up-
regulated reaching a peak on day 3 post transfection. This probably accounts for the synthesis 
of new proteins, in this case the RIG-I where the expression is driven by the CMV promoter, 
IFNa and Mx.  
The expression of all the target genes seems to follow the same pattern with peaks and 
declines on the same days in both RIG-I and MAVS-transfected ASK-cells which is plausible. 
The main difference observed with the RIG-I and MAVS-transfected ASK-cells is the 
stronger induction of IFNa on day 1 post transfection with MAVS-plasmids compared to the 
induction seen with RIG-I-plasmids on IFNa gene expression on the same day. This can also 
be observed for the IL-1β gene, where the up-regulation seen on day 1 post transfection is 
stronger with the MAVS-plasmids compared to the RIG-I-plasmids. 
It was investigated whether overexpressing RIG-I in CHSE-cells could confer any kind of 
protection of the cells against infection with these two pathogenic viruses. From our results it 
appears that RIG-I overexpression in CHSE-cells may give some protection against infection 
with IPNV (see Figure 34), but the same could not be observed for the ISA virus as the 
variation in these data was too large for any conclusion to be drawn. However, although the 
RIG-I transfection appears to protect the CHSE-cells in the fluorescence microscopy 
experiment, this was not observed when performing the TCID50 titration (data not shown). 
For the TCID50 titration, the situation was reversed, suggesting that MAVS-transfection could 
protect the cells against IPNV infection (Figure 36 and Figure 37).     
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When transfecting with RIG-I-GFP, this protein showed an even distribution throughout the 
cytosol of the cell. However more often than not, the RIG-I-GFP a couple of days after 
transfection, could be observed as vacuoles in close proximity to the cell nucleus which may 
suggest a saturation of the ER. Sometimes RIG-I-GFP even showed a co-localization with the 
nucleus as can be observed in Figure 33 in the right picture. Overexpressing RIG-I may alter 
the natural distribution of this protein in these cells. Whether this is attributed to the fact that 
the proteins are overexpressed or that the GFP-tag attached to the RIG-I and MAVS may alter 
the function and distribution of them, remains unclear. One should also keep in mind that the 
RIG-I-GFP is not the full-length RIG-I but the N-terminal end fused with the GFP and that 
this may also contribute to a possible alteration of subcellular distribution.    
However, it should be kept in mind that the transfection itself may induce immune responses 
and alter the transcription of the selected target genes investigated in this thesis, and that in 
this thesis, Q-PCR was not run on empty plasmid vector transfected cells as a control making 
the interpretation of the Q-PCR results for transfected cells more difficult to interpret. 
In summary our results may indicate that overexpression of RIG-I and MAVS may have some 
kind of protective effect against IPNV infection, but our results do not confirm this beyond a 
doubt. Further studies are required to investigate this. For ISAV no conclusive results were 
obtained regarding MAVS and RIG-I overexpression and if it could confer some protection 
against ISAV infection. This was due to the difficulties in observing CPE in infected cells 
with our ISAV4 isolate, after it had been propagated in ASK-cells. Even though the ISAV4 
isolate used in this thesis may have been attenuated in some way (either by excessive thawing 
and refreezing or to many passages), it did replicate in ASK-cells and made the cells present 
pathological changes like vacuolization in the infected cells and also induced IFNa up-
regulation in infected ASK-cells.     
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6: Concluding remarks and future direction 
Due to the significance of viral infection with IPN and ISA and their related mortalities in 
commercially cultured salmon populations, there is a strong interest aimed toward 
understanding viral infection in fish and the development of methods including vaccination to 
combat such outbreaks. Novel vaccines against IPNV and ISAV are needed as the available 
vaccines on the market do not prove to be sufficiently effective in controlling new disease 
outbreaks and preventing a carrier state in fish. Knowledge on RLR ligands and the way they 
activate the innate immune system begins to be exploited and certainly will in the future be 
important for vaccine development as teleost fish are more dependent on their innate immune 
system as their adaptive immune response is not as specific as the mammalian system. In this 
master thesis the viral infections with IPNV and ISAV and the immune responses they induce 
and also how the overexpression of MAVS and RIG-I could influence the infection 
progression were covered.  
A central issue that remains to be resolved is the intensity of the host response in a specific 
tissue targeted by viral infection. The fundamental role of the inflammatory response and its 
involvement in either resolution of viral infection or dysfunctional responses leading to the 
establishment of asymptomatic carriers or extensive tissue damage leading to a negative 
outcome is central and should be further investigated in the future. Understanding the 
complex network of cellular processes and virus-host interactions should aid in identifying 
new and common targets for the therapeutic intervention of virus infection aiding in 
producing novel vaccines. This effort must take advantage of the recent developments in 
functional genomics, bioinformatics and other emerging technologies as suggested by Katze 
et al [73].    
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